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Understanding comorbidity factors is essential for optimal stroke recovery. Up to 49% of patients 
develop protein-energy malnutrition (PEM) after stroke, but its effects have not been adequately addressed. 
The study objectives were to determine the effects of post-stroke PEM on the recovery of skilled locomotion 
and infarct size.  
Adult, male (12-week-old) Sprague-Dawley rats were trained to walk on a regular rung pattern in 
the horizontal ladder and tested prior to surgery to establish pre-stroke baseline. Rats (now 16 weeks old) 
were assigned to photothrombotic stroke targeting the forelimb motor cortex or sham surgery. On day 2, 
rats were tested on the regular ladder rung pattern before assignment to control (12.5% protein) or low 
protein (0.5%) diets and subdivision into subacute (studied until day 12) or chronic (day 28) groups (n=6-
10/group/study). On day 11, rats were tested on the regular pattern and a novel irregular pattern. Chronic 
study rats were tested again on day 27 on the regular and (no longer novel) irregular patterns. Food intake 
and body weight were monitored. Serum albumin concentration was measured by a spectrophotometric 
assay and liver lipid was measured by lipid extraction and dry lipid weight. Infarct volume was measured 
on cresyl violet stained brain sections.  
Feeding the low protein diet resulted in PEM by day 12, based on a decrease in body weight 
(ANOVA; p<0.030), daily food intake (p<0.019) and serum albumin concentration (p<0.001). A trend for 
increased liver lipid content in PEM rats became evident on day 28 (p=0.051). On the ladder regular pattern, 
stroke increased error rate only on day 2 (repeated measures ANOVA; p<0.001). On the irregular rung 
pattern, stroke rats had higher error rates relative to shams on days 11 and 27 (p<0.009). PEM rats exposed 
to stroke had more errors than the other groups when the irregular pattern data on d11 were combined from 
both studies (p<0.007). PEM did not alter infarct size on day 12 or 28 (t-test; p>0.05).  
In conclusion, post-stroke PEM worsened recovery on only the most challenging and novel walking 
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Chapter 1 INTRODUCTION 
1.1 Rationale 
Stroke refers to the sudden loss of brain function due to the disruption of cerebral blood flow. 
The most common type of stroke is ischemic stroke, which accounts for more than 87% of all 
stroke incidents (Mozaffarian et al., 2015). Stroke is a significant cause of long-term adult 
disability in Canada (Lindsay et al., 2010). Upper extremity motor deficit is the most prevalent 
form among post-stroke disabilities (Kleim et al., 2007). Although limited spontaneous recovery 
can occur after stroke that can be further promoted by rehabilitation (Murphy & Corbett, 2009), 
comorbidity factors such as diabetes, hypertension (Ginsberg, 2008), and malnutrition may hinder 
stroke recovery. 
Current stroke treatments are insufficient. Recombinant tissue plasminogen activator (rt-
PA), which dissolves the blood clot and restores blood flow, is the only validated medication for 
treating acute brain ischemia (Casaubon et al., 2015). However, less than 2% of patients receive 
the treatment (Albers et al., 2011) due to the disadvantage of having to give it within 4.5 hours 
after stroke and other contraindications (Casaubon et al., 2015). Recently, endovascular 
thrombectomy has emerged as another useful procedure to decrease mortality rates and improve 
functional outcome (Goyal et al., 2015). However, the operation requires highly trained health 
care teams (Meyers et al., 2011) and cannot be used as a universal treatment to stroke.  
The past three decades of research focused on discovering neuroprotective agents to disrupt 
acute ischemic events and to limit the death of injured neurons has had little success (Broussalis 
et al., 2012). Based on this failure and the emerging science of targeting neuroplasticity as a means 
of promoting stroke recovery (Carmichael, 2016), alternative strategies have been suggested for 
the current development of stroke treatments. The first recommendation is to investigate 
combination therapies to interrupt multiple pathways of the ischemic cascade driving neuronal 
death, rather than using a single neuroprotectant targeting only one pathway (Savitz & Fisher, 
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2007; Albers et al., 2011). The second recommendation is to pursue strategies to enhance long-
term stroke recovery through brain repair mechanisms, in addition to promoting neuroprotection 
during the acute phase (Cramer, 2008). Enhanced neuroplasticity plays a critical role in post-stroke 
brain recovery (Murphy & Corbett, 2009; Overman & Carmichael, 2014). Neuroplasticity refers 
to the brain reorganization phenomenon characterized by both functional and structural changes 
in neuronal networks that occurs in response to external experiences, such as practicing musical 
instruments (Pascual-Leone et al., 2005), playing video games (Bavelier et al., 2010; Hubener & 
Bonhoeffer, 2014), aerobic exercise (Bavelier et al., 2010), and brain injuries like traumatic brain 
injury and stroke (Murphy & Corbett, 2009). Post-stroke plasticity is characterized by increased 
levels of axonal sprouting, dendritogenesis, and synaptogenesis in the peri-infarct region, the 
region adjacent to the infarct where damaged neurons are still viable (Murphy & Corbett, 2009). 
Synaptic remodeling activity has been directly correlated with functional outcome after stroke 
(Carmichael, 2006; Li et al., 2010; Hinman et al., 2013).  
The third recommendation is to elucidate the impact of prevalent comorbidity factors, such 
as diabetes and hypertension, to achieve the optimal outcome after stroke (Ginsberg, 2008). My 
thesis research focused on investigating effects of post-stroke protein-energy malnutrition (PEM), 
an under-appreciated comorbidity factor. In industrialized countries such as Canada, protein-
energy malnutrition (PEM) is most common in seniors (Chapman, 2006) who are also at highest 
risk for stroke (Krueger et al., 2015). Anorexia (Soenen & Chapman, 2013), poor dentition, and 
dementia (Agarwal et al., 2013) are among the many contributors to PEM in elderly individuals. 
These factors may also account for the 16%-20% of stroke patients that are malnourished at the 
time of hospital admission for stroke (Yoo et al., 2008). However, the prevalence of PEM increases 
dramatically after stroke. Within the first week after stroke onset, 20-35% of patients become 
protein-energy malnourished (Foley et al., 2009); by the time of transferring to a rehabilitation 
unit, up to 49% are affected by PEM (Finestone et al., 1996; Poels et al., 2006). Dysphagia, or 
difficulty in swallowing, stands out as the primary risk factor for increased PEM incidence after 
stroke (Foley et al., 2009). Other factors such as physical impairments also contribute to the 
elevated post-stroke PEM prevalence (Bouziana & Tziomalos, 2011). 
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Limited clinical evidence suggests PEM is an independent predictor of poor outcome after 
stroke. The multicenter FOOD (Feed or Ordinary Food) trial demonstrated a possible relationship 
between malnutrition and increased functional dependence in the initial cohort of 3012 patients 
(Food Trial Collaboration, 2003). Evidence from several small clinical studies also suggests that 
PEM is associated with poor outcome after stroke (Davalos et al., 1996; Martineau et al., 2005; 
Yoo et al., 2008). However, significant methodological flaws prevent these studies from providing 
a definite answer to whether PEM is a direct cause of impaired recovery after stroke. Given the 
limitations of clinical studies to investigate the direct impact of malnutrition on brain repair after 
stroke, I employed rodent preclinical models in the thesis research to study whether there is a 
causal relationship between PEM and impaired functional (motor) recovery after cortical stroke.   
Using a rat model of cortical stroke, in which the infarct is placed in the forelimb region of 
the motor cortex, my laboratory colleagues have shown that post-stroke PEM does hinder the 
recovery of forelimb function. This was evident as decreased spontaneous use of the stroke-
affected forelimb during exploration in the cylinder task (Matwee, 2016). However, there are no 
studies that have investigated the effect of post-stroke PEM on recovery of skilled locomotion. 
Thus, the goal of the thesis research was to determine whether PEM developing after stroke 
detrimentally affects the recovery of locomotion, which requires skilled coordination of forelimbs 
and hindlimbs. I further hypothesized that a detrimental effect of PEM on walking recovery would 
not be due to increased  infarct size, since no such change was found in previous studies from my 
laboratory, either with PEM pre-existing at stroke onset (Alaverdashvili et al., 2018) or PEM 
developing after stroke (Matwee, 2016). In addition, it was reasoned that the infarct core would be 
well developed before PEM would be induced by a low protein diet introduced on day 2 after 
stroke (Lee et al., 1996). The thesis did not address other mechanisms underlying the effects of 
post-stroke PEM on skilled locomotion. However, previous findings from my laboratory have 
demonstrated that brain inflammation, brain plasticity, and the acute phase response may be key 
contributors to the detrimental effects on recovery from brain ischemia caused by PEM (Ji et al., 




PEM developing after cortical stroke will hinder the recovery of skilled locomotion in adult 
rats without increasing the infarct size. 
 
1.3 Research Objectives 
 1) To assess if PEM that develops after cortical stroke hinders the recovery of skilled 
locomotion in the horizontal ladder walking task. 

















Chapter 2 LITERATURE REVIEW 
2.1 Ischemic Stroke 
 Stroke refers to the sudden loss of brain function due to the disruption of cerebral blood 
flow. The most common type of stroke is an ischemic stroke, which is caused by emboli or thrombi 
occluding cerebral vessels and accounts for more than 87% of all stroke incidents (Mozaffarian et 
al., 2015). In other cases, the rupture of brain blood vessels induces hemorrhagic stroke (Broussalis 
et al., 2012). Throughout the thesis, the general term stroke is used to refer to ischemic stroke 
unless otherwise stated. 
 Stroke is a significant cause of long-term adult disability in Canada (Lindsay et al., 2010). 
Recently, it was estimated that approximately 405,000 individuals are living with effects of stroke 
in Canada (Krueger et al., 2015). It has been projected that by the year 2039 the number of people 
with permanent stroke disabilities will increase to between 654,000 and 726,000 (Krueger et al., 
2015). Depending on the severity and the location of the stroke in the brain, patients can suffer 
from learning impairment, memory loss, depression, dysphagia and functional motor deficit. 
Among these post-stroke disabilities, upper limb motor deficit is the most prevalent form (Kleim 
et al., 2007).  
The extent of recovery after stroke is a key factor determining the quality of life and 
productivity in long-term survivors. Although some limited spontaneous recovery can occur after 
stroke (Carmichael, 2016) that can be further promoted by rehabilitation (Murphy & Corbett, 
2009), comorbidity factors such as diabetes, hypertension (Ginsberg, 2008), and malnutrition may 
hinder stroke recovery. The study described here focuses on investigating the impact of protein-
energy malnutrition (PEM) developing after ischemic stroke, a comorbidity condition affecting up 





2.11 Pathophysiology of Ischemic Stroke 
In ischemic stroke, there are sudden loss of specific brain functions due to a disruption of 
the cerebral blood flow caused by a blood clot (Mozaffarian et al., 2015). Normal cerebral blood 
flow is approximately 50-60mL/100g brain tissue/min, with less than 10mL/100g brain tissue/min 
resulting in irreversible neuron death (Broussalis et al., 2012). Two types of blood clots cause 
ischemic stroke; a local thrombus that is mainly a result of atherosclerosis can cause cerebral artery 
occlusion, or an embolus can travel into a cerebral artery (mostly in the middle cerebral artery 
area) and disrupt the blood flow (Broussalis et al., 2012). 
The pathophysiology of acute brain ischemia is complex and multifaceted. The initial blood 
flow reduction rapidly triggers the ischemic cascade, which consists of a series of biochemical 
reactions that include adenosine triphosphate (ATP) depletion, prolonged depolarization, 
glutamate excitotoxicity, increased intracellular calcium level, elevated oxidative stress, increased 
free radical generation, excess activation of pro-inflammatory molecules, and disruption of the 
blood-brain barrier (Durukan & Tatlisumak, 2007; Broussalis et al., 2012).Within minutes, 
irreversible neuron death occurs and forms an initial infarct core (Durukan & Tatlisumak, 2007; 
Heiss, 2012). At the core, most brain cells die through necrosis (Dirnagl et al., 1999). The 
penumbra refers to the peripheral region adjacent to the infarct core, where blood flow is disrupted 
to a lesser extent; the ischemic damage is detrimental enough to halt physiological functions of 
this brain region but not enough to cause immediate neuron death (Paciaroni et al. 2009). 
Compromised brain cells in the penumbra can proceed to apoptosis (programmed cell death) or 
may be partially or completely rescued if blood flow is restored promptly. Saving the penumbra is 
the target for developing acute neuroprotection drug therapy (Broussalis et al., 2012). 
 
2.1.2 Current Acute Stroke Treatments and Neuroprotective Agents 
Despite the high prevalence and the devastating effects of stroke, current treatments are 
insufficient. Recombinant tissue plasminogen activator (t-PA), which dissolves the blood clot and 
restores blood flow, is the only validated medication for treating acute brain ischemia (Casaubon 
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et al., 2015). Although international guidelines have extended the administration window of t-PA 
from within 3 hours to 4.5 hours after stroke, less than 2% of patients receive the treatment (Hacke 
et al., 2008; Albers et al., 2011). In addition to the large number of patients not arriving at the 
hospital in time, contraindications disqualify additional patients from receiving this treatment.  
Recently, surgical interventions that mechanically remove the blood clot have emerged as 
another promising approach to treat acute ischemic stroke (Mack, 2016). For instance, the 
ESCAPE trial has shown that endovascular thrombectomy can decrease mortality rates and 
improve functional outcome for patients having a small infarct core in a cerebral artery proximal 
to middle cerebral arteries (Goyal et al., 2015). However, only a small percentage of patients 
qualify to undergo this surgery, and these procedures require highly trained healthcare teams 
(Meyers et al., 2011). Therefore, mechanical thrombectomy cannot be used as a universal 
treatment for stroke.  
The research focused on discovering neuroprotective agents to disrupt acute ischemic events 
and to prevent the death of injured neurons in the penumbra was initiated in the 1980s (Ginsberg, 
2008; Broussalis et al., 2012). Despite the many positive findings obtained in animal studies, there 
has been no successful translation of any neuroprotective agent into the clinic in the past three 
decades (Ginsberg, 2008; Broussalis et al., 2012). A number of factors account for the failure 
(Ginsberg, 2008; Broussalis et al., 2012). The primary reason is that in animal studies, 
neuroprotective agents were often given immediately after stroke or even before stroke whereas 
such a short therapeutic window is not practical in human patients (Ginsberg, 2008; Broussalis et 
al., 2012). Moreover, outcome endpoints measured in animal studies are often different from those 
in clinical trials. Also, young and healthy animals are frequently used whereas stroke patients are 
commonly elderly and have other comorbidities. Other factors such as the lack of long-term animal 
studies utilizing functional endpoints (Savitz & Fisher, 2007) and the challenge of studying the 
diverse stroke types in human patients also contributed to the failed neuroprotection approach 
(Broussalis et al., 2012).  
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More efficient restorative interventions are in demand as the number of individuals living 
with stroke disabilities continues to increase (Krueger et al., 2015). Based on the failure to develop 
neuroprotection agents and the emerging science of targeting neuroplasticity as a means of 
promoting long-term stroke recovery (Carmichael, 2016), alternative strategies have been 
suggested for the current development of stroke therapy. Rather than using a single neuroprotectant 
targeting only one pathway, therapies aiming to interrupt multiple pathways of the ischemic 
cascade should be investigated (Savitz & Fisher, 2007; Ginsberg, 2008; Broussalis et al., 2012). 
In addition to promoting neuroprotection during the acute phase, enhancing long-term stroke 
recovery through brain repair mechanisms is an alternative approach to treat stroke (Cramer, 2008; 
Carmichael, 2016). Also, the effects of common comorbidity factors such as diabetes and 
hypertension on stroke recovery should be understood to achieve optimal recovery (Ginsberg, 
2008). My thesis project focuses on understanding protein-energy malnutrition (PEM) developing 
after stroke, another prevalent comorbidity factor that is under-appreciated. 
 
2.1.3 Post-Stroke Neuroplasticity 
  Limited spontaneous recovery after stroke can be observed in patients, and this can be 
further enhanced by interventions such as physical rehabilitation and transcranial magnetic 
stimulation (Murphy & Corbett, 2009; Corbett et al., 2014). The resolution of some detrimental 
factors, such as the subsiding of edema, reduced intracranial pressure, and the restoration of 
cerebral blood flow, account for some of the post-stroke recovery (Lee & van Donkelaar, 1995). 
Aside from these factors, injury-induced neuroplasticity is another critical mechanism contributing 
to post-stroke brain recovery (Cramer, 2008; Murphy & Corbett, 2009; Hosp & Luft, 2011; 
Overman & Carmichael, 2014). In general, neuroplasticity in the brain refers to the brain 
reorganization phenomenon characterized by both functional and structural changes in neuronal 
networks (Fu & Zuo, 2011). Previously, it was believed that neuronal networks lost their 
neuroplasticity by the end of the critical period during early brain development and remained fixed 
throughout the lifespan (Fu & Zuo, 2011). In recent decades, cumulative data have demonstrated 
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that in the adult brain, neuronal networks can undergo rewiring and remapping in response to 
external experiences, such as practicing musical instrument (Pascual-Leone et al., 2005), playing 
video games (Bavelier et al., 2010; Hubener & Bonhoeffer, 2014), and aerobic exercise (Bavelier 
et al., 2010).  
Plasticity in adult brain can be further stimulated by brain injuries like traumatic brain 
injury and stroke (Murphy & Corbett, 2009). Similar to developmental plasticity, stroke-induced 
brain plasticity is characterized by a rapid increase of axonal sprouting, dendritogenesis, and 
synaptogenesis, which are critical plasticity events contributing to functional recovery (Corbett et 
al., 2014). Therefore, enhancing post-stroke plasticity has become an essential target to promote 
optimal stroke recovery. As stated above, upper extremity impairment is the most common deficit 
observed in human patients, as stroke often causes damage in the sensorimotor cortex (Cassidy & 
Cramer, 2017). Given this observation, my thesis project focuses on the functional recovery of the 
forelimb in a rodent photothrombotic stroke model targeting the sensorimotor cortex. The 
following section outlines some of the current knowledge of post-stroke cortical neuroplasticity.  
 Structural changes of post-stroke plasticity lead to the remapping and rewiring of certain 
neuronal networks that can serve as compensation for lost neurons and their contributions to brain 
functions; this post-stroke reorganization process is considered as an essential mechanism 
contributing to spontaneous recovery, and it can be further enhanced by external treatments 
(Brown et al., 2009; Clarkson et al., 2013; Corbett et al., 2015). Structural changes occur in both 
the peri-infarct region (adjacent to the infarct) as well as distal areas away from the infarct. The 
majority of changes takes place in the peri-infarct region (Murphy & Corbett, 2009) and are found 
to positively correlate with functional recovery (Carmichael, 2006; Li et al., 2010; Hinman et al., 
2013). In a severe stroke, the contralesional cortex also undergoes reorganization as there is little 
spared tissue left in the ipsilesional hemisphere (Murphy & Corbett, 2009). However, the role of 
contralesional cortex in functional recovery remains unclear (Corbett et al., 2015). Furthermore, it 
has been shown that corticospinal projections descending from the contralesional cortex can cross 
the midline and make new connections on the denervated side of the spinal cord (Zhao et al., 
2013). In addition to the reorganization of existing neuronal networks, neurogenesis (the process 
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of generating new neurons) has been found to play a limited role in post-stroke functional recovery 
as well. Upon an ischemic insult, neuron precursor cells originating from the subventricular zone 
and dentate gyrus in the hippocampus migrate towards the infarct region (Wang et al., 2012). The 
deprivation of intrinsic neurogenesis has been shown to hinder post-stroke functional recovery, 
which indicates neurogenesis indeed can contribute to stroke recovery (Wang et al., 2012). In fact, 
only a few neuron precursor cells reach the peri-infarct region and mature into functional neurons, 
whereas most of them die during migration (Corbett et al., 2014). These data, and others (Zhao et 
al., 2008; Bai et al., 2015; Cook et al., 2017), suggest that neuroprotective and neurotrophic factors 
released from neuron precursor cells, rather than newly born neurons reaching the peri-infarct site 
and integrating into the network, contribute to the beneficial effect of neurogenesis on functional 
recovery (Murphy & Corbett, 2009; Corbett et al., 2015). 
Heightened structural reorganization in the peri-infarct region occurs along with a series of 
changes in growth-related genes and molecules that include neurotransmitters, neurotrophins, 
hormones, and growth factors (Carmichael et al., 2005; Murphy & Corbett, 2009). The majority 
of changes in the level of these molecules takes place during a critical period when most prominent 
functional recovery is observed (Wieloch & Nikolich, 2006; Corbett et al., 2015). This critical 
period can be categorized into four stages based on studies relying on different preclinical stroke 
models in both rats and mice (Carmichael et al., 2005; Carmichael, 2006; Corbett et al., 2014; 
Overman & Carmichael, 2014; Corbett et al., 2015): 1) the triggering stage, that occurs in first few 
days after stroke, when neuroplastic signals are induced by the stroke injury; 2) the initiating stage, 
at 1 week after stroke, during which levels of growth-promoting molecules are upregulated; 3) the 
maintenance stage, at 2 weeks after stroke, when extensive axonal sprouting happens; and 4) the 
maturation stage, at 4 weeks after stroke and beyond, when levels of growth-promoting molecules 
start to decrease, levels of growth-inhibitory molecules are increased. and new patterns of cortical 
projections can be detected.  
Brain abundant membrane attached signal protein 1 (CAP-23), c-Jun, small proline-rich 
region protein 1 (SPRR1), and growth-associated protein-43 (GAP-43) are among the most 
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prominent growth-promoting molecules upregulated in the peri-infarct region (Stroemer et al., 
1995; Carmichael et al., 2005). GAP-43 is a protein found abundantly in the growth cone (the tip 
of a growing axon) during both extensive axonal growth at the early brain development (Denny, 
2006) and heightened axonal sprouting in the post-stroke peri-infarct cortex of the adult brain 
(Carmichael et al., 2005). The level of GAP-43 declines once growth cones collapse and new 
synapses are formed (Denny, 2006). In the healthy adult brain where limited axonal sprouting 
takes place, GAP-43 is present at a low level in the primary sensorimotor cortex and other brain 
regions (Denny, 2006). Both messenger RNA and protein levels of GAP-43 are upregulated in the 
peri-infarct region within the first few days after stroke, which can last for one month and beyond 
(Carmichael et al., 2005). It is believed that the upregulation of GAP-43 plays a crucial role in 
post-stroke axonal sprouting (Carmichael et al., 2005; Carmichael, 2006; Jeffers et al., 2014).  
Following axonal sprouting, new synapses are formed between surviving neurons in the peri-
infarct region and neurons in the adjacent spared cortex. The elevated level of synaptogenesis 
results in an increased synaptic density in the peri-infarct region, which is often characterized by 
an enhanced level of a synaptic protein, synaptophysin. Synaptophysin is the most abundant 
integral membrane protein (~6-8%) in synaptic vesicles and plays an essential role in 
neurotransmission (Thiel, 1993). For example, the level of synaptophysin was significantly 
upregulated after stroke in the middle cerebral artery occlusion (MCAO) model in rats (Stroemer 
et al., 1992), marking the formation of new connections in the peri-infarct region.  
At the maturation stage, levels of growth-promoting molecules start to fall while initially 
regressed growth-inhibitory molecules begin to upregulate again to facilitate scar formation and 
to stabilize newly formed connections (Corbett et al., 2014; Overman & Carmichael, 2014). The 
majority of these inhibitory proteins are myelin-associated proteins such as Nogo A, extracellular 
matrix proteins such as chondroitin sulfate proteoglycans (CSPGs) and others such as Ephrin-A5 
(Carmichael et al., 2005). It has been shown that the deprivation of peri-infarct chondroitin sulfate 
proteoglycans along with a specific motor training regimen can improve functional outcome in a 
rat stroke model (Gherardini et al., 2015). Since growth-inhibitory molecules hinder post-stroke 
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neuroplasticity, blocking their upregulation is considered another treatment approach aimed at 
extending the growth-promoting time window after stroke. 
Ischemic cerebral injury triggers a series of brain inflammatory events that primarily 
involve microglia, blood-borne macrophages and astrocytes (Anrather & Iadecola, 2016; Kim & 
Cho, 2016). Once considered as a negative contributor to stroke recovery, a growing body of 
evidence have demonstrated that the role of brain inflammation in stroke recovery is rather 
complex as it can be both  beneficial and detrimental (Anrather & Iadecola, 2016). Microglia, the 
primary immune cells resident in the brain, are the first responders to ischemic stroke (Guruswamy 
& Elali, 2017). Monocyte-derived macrophages, which infiltrate later through the compromised 
blood-brain-barrier, also play an essential role in neuroinflammation (Kim & Cho, 2016). 
Depending on the microenvironment, microglia and macrophages can polarize into two primary 
phenotypes: the M1 subtype with pro-inflammatory nature and the M2 that is anti-inflammatory 
(Kim & Cho, 2016). Moreover, M1 and M2 subtypes are interchangeable under certain 
environments (Kim & Cho, 2016). The M1 subtype of microglia and macrophages releases pro-
inflammatory cytokines such as tumor necrosis factor α, interleukin 1 and interleukin 6 that lead 
to increased ischemic injury (Kim & Cho, 2016; Guruswamy & Elali, 2017). The M2 subtype of 
microglia and macrophages is involved in cleaning up the debris of dead cells (Kim & Cho, 2016; 
Guruswamy & Elali, 2017). Additionally, M2 subsets secrete anti-inflammatory molecules, 
including transforming growth factor β and interleukin 10 that dampen inflammation to re-
establish tissue homeostasis (Kim & Cho, 2016; Guruswamy & Elali, 2017). Moreover, growth 
factors, such as vascular endothelial growth factor and insulin growth factor-1, are expressed by 
microglia and macrophages to facilitate angiogenesis and neuroplasticity processes in the peri-
infarct region (Kriz & Lalancette-Hebert, 2009; Iadecola & Anrather, 2011).  
Astrocytes become activated upon ischemic insult (Pekny et al., 2014). Reactive astrocytes 
have several beneficial functions, including removing excessive glutamate (the excitotoxic 
neurotransmitter released during the ischemic cascade), secreting neurotrophic factors such as 
brain-derived neurotrophic factor (BDNF) and glial-derived neurotrophic factor, and forming a 
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glial scar that isolates the lesion area from the rest of the brain (Gleichman & Carmichael, 2014; 
Pekny et al., 2014). The downside of reactive astrocytes is that a range of growth-inhibitory 
molecules are expressed that would inhibit axonal sprouting (Gleichman & Carmichael, 2014; 
Pekny et al., 2014). Moreover, astrocytes influence the recruitment and activation of microglia 
(Pekny et al., 2014). It appears that reactive astrocytes suppress activated microglia while the 
excess activation of microglia indicates an impaired astrocyte response (Pekny et al., 2014). 
In general, ischemic stroke triggers a neuroinflammatory response involving the 
mobilization and activation of microglia, macrophages, astrocytes, and other peripheral 
leukocytes. The development of this response greatly impacts the extent of post-stroke 
neuroplasticity (Gleichman & Carmichael, 2014; Hu et al., 2015) and functional outcome 
(Iadecola & Anrather, 2011). Furthur understanding of post-stroke neuroinflammation is vital as 
it may provide therapeutic targets to enhance stroke recovery. 
 Currently, physical rehabilitation is one of several approaches developed to improve 
functional recovery by enhancing neuroplasticity. In animal models, enriched rehabilitation is most 
effective when provided during the early critical period after stroke when neuroplasticity processes 
are most prominent (Corbett et al., 2015). Enriched rehabilitation can increase synaptic activities 
in the peri-infarct region and upregulates the level of BDNF (Livingston-Thomas et al., 2016). 
Another pre-clinical study demonstrated that constraint-induced movement therapy (CIMT) was 
able to increase the number of synapses from descending corticospinal tracts and to inhibit the 
level of Nogo A, a growth-inhibitory molecule, in the peri-infarct region (Zhao et al., 2013). 
Moreover, the combination of a growth factor infusion (epidermal growth factor and 
erythropoietin) and rehabilitation significantly accelerated functional recovery in animals (Jeffers 
et al., 2014). Directly blocking CSPGS that are growth-inhibitory also enhanced the effect of a 
specific training program in rats (Gherardini et al., 2015). However, current clinical rehabilitation 
regimes are often not sufficient to fully restore impaired functions, and patients are usually left 
with permanent deficits (Livingston-Thomas et al., 2016). One criticism is that clinical 
rehabilitation is usually introduced at a late stage rather than during the critical early period 
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(Corbett et al., 2014). A lack of physical activities and prolonged bed rest within the first few 
weeks after stroke may further suppress neuroplasticity-induced recovery (Corbett et al., 2014). 
Therefore, it is now proposed that task-specific physical rehabilitation should be combined with 
other adjunct therapies to achieve optimal functional recovery. A great effort still needs to be made 
to fully understand and refine rehabilitation approaches in both human patients and animal models. 
Transcranial magnetic stimulation and stem cell therapy are another two restorative 
treatments under development. In a mouse stroke model, repeated brain stimulations were shown 
to increase the level of BDNF and nerve growth factor in the peri-infarct region, but no such change 
was seen in healthy mouse brains, indicating that only injured brains are sensitive to this treatment 
(Cheng et al., 2014). Transplantation of stem cells into the peri-infarct region has also shown 
promise to improve functional outcome in animals, but significant disadvantages must be 
overcome for this to become a reliable treatment (Corbett et al., 2015). Although results from 
clinical trials of transcranial magnetic stimulation (Klomjai et al., 2015) and stem cell therapy 
(Eckert et al., 2013) are not definitive, these two approaches still hold great promise to become 
safe and efficient stroke therapies with further research.  
Overall, it is suggested that combinational treatment regimens including physical 
rehabilitation, socialization, and other adjunct therapies need to be developed for the best recovery 
(Corbett et al., 2014). Furthermore, understanding and eliminating common co-morbidity factors 
such as hypertension and diabetes, are essential to achieve optimal functional recovery after stroke 
(Mozaffarian et al., 2015). My research is based on the premise that another common co-morbidity 
factor, PEM, could also adversely affect the recovery of walking ability after stroke through 




2.2 Post-Stroke PEM and Recovery from Ischemic Stroke 
2.2.1 Prevalence and Causes of PEM in Stroke Patients  
 Protein-energy malnutrition (PEM) refers to the nutritional status in which protein and 
energy are inadequate to meet metabolic requirements, resulting in altered body compositions and 
impaired biological functions (Bouziana & Tziomalos, 2011; van der Pols-Vijlbrief et al., 2014). 
In industrialized countries such as Canada, PEM is highly prevalent in community-dwelling 
seniors and nursing home residences (Chapman, 2006; Morley, 2012; van der Pols-Vijlbrief et al., 
2014). A German study showed that while 12% of a sample of over 290 seniors receiving home 
care were malnourished, more than half of the seniors in the study were at risk for malnutrition 
(Kiesswetter et al., 2013). Seniors are also at the highest risk for developing stroke (Krueger et al., 
2015). PEM alone can cause serious adverse effects, including low body weight, decreased muscle 
mass and strength, increased dependence, and elevated mortality rate (Chapman, 2006; Morley, 
2012; Kiesswetter et al., 2013). Anorexia caused by aging and medications, poor dentition, social 
isolation, and chronic diseases are among contributors to undernutrition that develops in elderly 
individuals (Chapman, 2006; Bouziana & Tziomalos, 2011; Agarwal et al., 2013; Soenen & 
Chapman, 2013; van der Pols-Vijlbrief et al., 2014; Sabbouh & Torbey, 2017), and thus may 
account for many of those cases of PEM that co-exist at the time of stroke. It is estimated that 
approximately 16%-20% of stroke patients are undernourished at the time of hospital admission 
for stroke (Finestone et al., 1995; Gariballa et al., 1998; Martineau et al., 2005; Crary et al., 2006; 
Yoo et al., 2008; Sabbouh & Torbey, 2017). 
 The prevalence of PEM increases dramatically after stroke (Finestone et al., 1995; 
Bouziana & Tziomalos, 2011; Peters et al., 2015; Sabbouh & Torbey, 2017). Within the first week 
after stroke onset, 20-35% of patients become protein-energy malnourished (Foley et al., 2009). 
By the time of transferring to a rehabilitation unit, up to 49% of stroke patients can be affected by 
PEM (Finestone et al., 1996; Poels et al., 2006). Differences in assessment time, patient 
population, and assessing methods can account for the variability in prevalence rates among 
studies (Marshall, 2016). Dysphagia, or difficulty in swallowing, causes substantially reduced 
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nutritional intake, and this affects up to 65% of all stroke patients at the acute stage (Gonzalez-
Fernandez et al., 2013; Hebert et al., 2016; Sabbouh & Torbey, 2017). Thus, dysphagia stands out 
as a significant risk factor for malnutrition developing after stroke (Foley et al., 2009; Mould, 
2009; Bouziana & Tziomalos, 2011; Cohen et al., 2016). Other factors such as post-stroke 
depression, dysphasia (impaired speech ability), poor oral hygiene, reduced mobility, and 
hemiplegia also contribute to impaired self-feeding ability, inadequate nutritional intake, and 
elevated post-stroke PEM prevalence (Finestone et al., 1995; Bouziana & Tziomalos, 2011; 
Sabbouh & Torbey, 2017).  
 Although many nutritional assessment tools, such as Subjective Global Assessment and 
Mini Nutritional Assessment, have been developed (Morley, 2012; Agarwal et al., 2013; Peters et 
al., 2015), a gold standard for assessment is lacking for stroke patients. No nutritional assessment 
protocol has been validated specifically for stroke and its subtypes (Peters et al., 2015). Moreover, 
invalidated methods or modified, simpler versions were frequently used by registered dietitians 
for stroke patients when assessed in a recent Canadian national survey conducted across 125 
Canadian health institutions (Peters et al., 2015). These drawbacks can lead to the misdiagnosis of 
PEM and the underestimation of malnutrition rates among stroke patients. Although a persistent 
issue for the past 20 years, post-stroke malnutrition is under-appreciated and undertreated 
(Sabbouh & Torbey, 2017). By studying the impact of post-stroke PEM in carefully controlled 
preclinical models, my research aims to determine the impact of untreated post-stroke PEM on the 
recovery of walking after cortical stroke.  If results are significant, this could enhance clinical 
awareness of the importance of properly screening and correcting PEM in stroke patients. 
 
2.2.2 Evidence that Post-Stroke PEM Impairs Recovery after Stroke  
The FOOD (Feed or Ordinary Food) study, an international multicenter, randomized trial, 
demonstrated a possible relationship between compromised nutritional status at hospital admission 
and increased functional dependence at six months after stroke in the initial cohort of 3012 patients 
(Food Trial Collaboration, 2003). However, significant methodological flaws, such as using 
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different non-standardized nutritional assessments across centers and the lack of ongoing 
nutritional monitoring across the study period, prevented this study from providing a definite 
answer to whether PEM is a direct cause of impaired stroke recovery.  
Evidence from several small clinical studies also suggests that PEM is an independent 
predictor of poor stroke recovery. Pre-existing malnutrition was shown to be associated with an 
increased length of hospital stay and an increased rate of post-stroke complications (Martineau et 
al., 2005). Malnutrition developing after stroke is also associated with a higher mortality rate, 
lower functional scores, and extended hospital stay (Davalos et al., 1996; Sabbouh & Torbey, 
2017). Moreover, extensive weight loss and reduced muscle strength result in decreased hand 
gripping strength, which may reduce the ability of patients to fully engage in rehabilitation (Ha et 
al., 2010). Another study in ischemic stroke patients showed that undernutrition emerged within 
the first week of admission independently predicted poor functional outcome at three months (Yoo 
et al., 2008). Another study found similar results that the worst functional recovery by six months 
was observed in stroke patients with low body mass indices and low serum albumin levels (Kimura 
et al., 2017). On the other hand, improved nutritional status during rehabilitation was correlated 
with better functional outcome (Nishioka et al., 2016). Recently, some clinical studies tried to 
answer the question whether nutritional supplements can improve functional outcome in 
undernourished stroke patients, which the large FOOD trial failed to answer (Dennis et al., 2005). 
For instance, a single-site study found that intensive nutritional treatment given to malnourished 
stroke patients was correlated with a better motor outcome after rehabilitation (Rabadi et al., 2008). 
However, this finding was limited by a small sample size and other drawbacks.  
Clinical studies have drawn interesting associations between PEM and aspects of post-stroke 
recovery.  However, they have been unable to investigate cause-effect relationships between PEM 
and motor recovery, brain repair, and its underlying mechanisms after stroke. Thus, our laboratory 
uses rodent stroke models to investigate whether such a causal relationship exists. Previously, we 
reported that PEM alone (without stroke) could induce a motor deficit; this was identified as 
alterations in skilled locomotion in the horizontal ladder walking task in adult rats (Alaverdashvili 
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et al., 2015a). Recently, we found that PEM pre-existing at stroke onset exacerbated forelimb 
abnormalities induced by cortical stroke in adult male rats (Alaverdashvili et al., 2018). Also, PEM 
introduced on day 4 after a photothrombotic stroke (targeted to the forelimb region of the motor 
cortex) hinders the spontaneous recovery of forelimb function, evident as a decrease in the use of 
the forelimb affected by the stroke during spontaneous exploration in the cylinder task (Matwee, 
2016). In my study, this work is extended to determine whether PEM developing after stroke 
affects the spontaneous recovery of skilled locomotion, which requires the use and coordination 
of forelimbs and hindlimbs. This objective was studied using the horizontal ladder task.  
 
2.2.3 Mechanisms by Which Post-Stroke PEM May Impair Recovery 
 It is proposed that PEM could hinder stroke recovery in several ways. First of all, PEM 
developing after stroke could impair those mechanisms of post-stroke brain repair (Carmichael, 
2016) that are significant players in stroke recovery. Our previous data have demonstrated that 
pre-existing PEM altered the expression of GAP-43 and tyrosine receptor kinase B (trkB), the 
primary receptor for BDNF (Prosser-Loose et al., 2010), which might partially explain the poorer 
functional (cognitive) outcome after global brain ischemia in malnourished gerbils (Bobyn et al., 
2005); this model mimics the reduction in blood flow to the entire brain that can occur in conditions 
such as cardiac arrest (Harukuni & Bhardwaj, 2006). Both GAP-43, an axonal sprouting marker 
(Carmichael et al., 2017), and BDNF, a neurotrophic factor (Corbett et al., 2015), are essential 
molecules involved in the events of post-stroke neuroplasticity. However, these findings relate to 
the pre-existing PEM that is present in 16~20% of stroke patients at admission. My thesis project 
extends this research to focus on the PEM that develops after stroke, which can affect up to 49% 
of patients. More recently, our laboratory demonstrated that PEM developing after global brain 
ischemia decreased the expression of GAP-43 and synaptophysin in the cornu ammonis 3 (CA3) 
region of the hippocampus at post-stroke day 21 (Smith et al., 2014). These data suggest that brain 
ischemia-induced plasticity can also be affected by post-stroke PEM. Limitations of this study are 
that the results are restricted to global ischemia, which primarily affects the cornu ammonis 1 
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(CA1) subregion of the hippocampus (Harukuni & Bhardwaj, 2006), and the link between the 
expression of these proteins and functional outcome was not studied. The thesis research addresses 
the question of whether post-stroke PEM impairs motor recovery after cortical stroke.  
Secondly, PEM may alter post-stroke brain inflammation, which, in turn, affects the 
neuronal repair process. Our previous work has shown that pre-existing PEM increased the 
reactive gliosis after global ischemia in a subset of gerbils (Bobyn et al., 2005). Further 
examination demonstrated that pre-existing PEM elevated the activation of hippocampal nuclear 
factor κB (NFκB), a transcription factor involved in the ischemic cascade during the acute phase 
after global ischemia (Ji et al., 2008). This suggested that PEM might amplify post-stroke 
inflammation. However, these findings are limited to global brain ischemia. When pre-existing 
PEM was examined in a rat cortical stroke model affecting the motor cortex, a mimic of the more 
common ischemic stroke, reduced astrogliosis and microglia activation were observed in the peri-
infarct region (Alaverdashvili et al., 2018). This mechanism may partially explain the elevated 
stroke-induced walking deficit present in the malnourished rats (Alaverdashvili et al., 2018). It is 
unknown if this pattern is different when PEM develops after stroke. 
Thirdly, PEM can independently induce an acute phase response (Dziedzic, 2015), which 
could indicate increased systemic inflammation. PEM induced in adult rat results in a decreased 
concentration of serum albumin, a negative acute phase protein (Andrade Ramos, 2013; 
Alaverdashvili et al., 2015a). The decrease is also contributed by decreased dietary protein supply. 
In addition, PEM in adult rats increases the serum concentration of α2-macroglobulin 
(Alaverdashvili et al., 2015a), a positive acute phase protein (Dziedzic, 2015). While acute phase 
proteins are nonspecific indicators of systemic inflammation (Gabay & Kushner, 1999), it is 
noteworthy that poor stroke outcome has been associated with a heightened and/or prolonged acute 
phase response (Dziedzic, 2008; Idicula et al., 2009) that can be induced by post-stroke PEM.  
 Lastly, PEM can induce abnormalities in muscle size and function that could detrimentally 
affect the recovery of walking ability. My laboratory has shown that PEM can cause atrophy of 
gastrocnemius medialis (Alaverdashvili et al., 2015a), a major muscle in the hindlimb of rats that 
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contains a high number of fast-twitching muscle fibers relative to slow-twitching muscle fibers 
(Delp & Duan, 1996). This muscle atrophy can induce muscle weakness and may partially explain 
the gait abnormality and hindlimb dysfunction observed in malnourished rats (Alaverdashvili et 
al., 2015a). While muscle wasting and weakness caused by protein-energy malnutrition or protein 
deficiency is a well-acknowledged phenomenon in clinical populations (Norman et al., 2011), 
further study is required to determine to what extent PEM can hinder stroke recovery by inducing 
skeletal muscle dysfunction. 
 
2.3 Stroke Models of Focal Ischemia in Rodents 
2.3.1 Overview 
Given the highly heterogeneous nature of human stroke, many stroke models in rodents aim 
to address different aspects of the complexity in clinical stroke (Harukuni & Bhardwaj, 2006; 
Corbett et al., 2017; McCabe et al., 2017; Sommer, 2017). Researchers should choose a model 
based on their study objectives and consideration of strengths and limitations of the model. There 
are two main categories of preclinical stroke models: global ischemia models, such as the two-
vessel occlusion model, induce a reduction in blood flow to the entire brain (Harukuni & Bhardwaj, 
2006), and focal ischemia models result in a localized infarct core in a specific region of the brain 
(Kumar et al., 2016).  
 Among focal ischemia models available, most commonly used models are middle cerebral 
artery occlusion (MCAO) model, endothelin-1 vasoconstriction model and photothrombotic model 
(Corbett et al., 2017; McCabe et al., 2017). To overcome the previous failure of translational 
research solely relying on young and healthy animals, both sexes, older animals, and animals with 
various clinically relevant comorbidity factors should be used as they better resemble the majority 
of clinical patients (Fisher et al., 2009; Corbett et al., 2017; McCabe et al., 2017; Sommer, 2017). 
Thus, studying the comorbidity factor, PEM, addresses a critical translational issue for promoting 
recovery after stroke.  
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Several methods are used to induce MCAO. Distal MCAO can be induced by transiently 
clipping distal branches of the middle cerebral artery whereas permanent occlusion can be 
achieved by cauterizing its branches (Durukan & Tatlisumak, 2007; Corbett et al., 2017). This 
method requires highly-trained surgeons and invasive surgical procedures, including craniotomy 
(Durukan & Tatlisumak, 2007; Murphy & Corbett, 2009; Fluri et al., 2015). The infarct produced 
by distal MCAO is primarily confined to the cortex (Durukan & Tatlisumak, 2007; Murphy & 
Corbett, 2009). Alternatively, a more significant injury can be produced by occluding proximal 
ends of the middle cerebral artery (Murphy & Corbett, 2009). The occlusion can also be achieved 
by inserting an intraluminal filament (or a coated suture) through internal cerebral artery into the 
origin of the middle cerebral artery and the filament can be withdrawn or left in to achieve transient 
or permanent occlusion (Kumar et al., 2016; McCabe et al., 2017; Sommer, 2017). Proximal 
MCAO produces a massive infarct affecting both the striatum and the cortex, which is commonly 
seen in clinical stroke (Corbett et al., 2017; McCabe et al., 2017). Although various types of 
filament have been designed to overcome the problem (McCabe et al., 2017), this method still 
carries a high risk of subarachnoid hemorrhage, and the infarct size is inconsistent (Fluri et al., 
2015; Kumar et al., 2016). Another variation of MCAO is to introduce an artificial embolus (a 
blood clot) into the internal carotid artery (Bacigaluppi et al., 2010; Kumar et al., 2016; McCabe 
et al., 2017; Sommer, 2017). If the embolus breaks down, multiple infarcts can be generated 
(McCabe et al., 2017). This model provides an excellent tool to study thrombolytic therapies and 
is the closest to mimicking a human ischemic stroke (Kumar et al., 2016; McCabe et al., 2017). 
However, the high mortality rate limits this model from being frequently used (Murphy & Corbett, 
2009). Overall, advantages of the MCAO model are that the location of the infarct closely mimics 
the majority of clinical strokes as they often occur in the region of middle cerebral arteries and the 
model creates a well-defined penumbra of considerable volume, with mechanisms of repair at play 
that are very valuable for studying neuronal repair (Lo, 2008; Corbett et al., 2017; Sommer, 2017). 
However, due to the involvement of invasive surgical procedures and the low reproducibility, 
MCAO models are not ideal for my study. 
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Local injection of endothelin-1, a potent vasoconstrictor, can produce ischemic stroke by 
constricting blood vessels (Durukan & Tatlisumak, 2007; Murphy & Corbett, 2009; Corbett et al., 
2017; McCabe et al., 2017). Endothelin-1 can be stereotaxically injected into a region of the brain 
parenchyma to produce a cortical stroke or be injected near a middle cerebral artery to achieve a 
damage involving subcortical structures such as the striatum (Corbett et al., 2017; McCabe et al., 
2017). Although the method is relatively easy, many disadvantages have been reported. Firstly, 
the infarct does not occur at the injection site, therefore it can be difficult to be precise (Bacigaluppi 
et al., 2010; Kumar et al., 2016). Secondly, endothelin-1, independent of its ability to cause 
vasoconstriction, can alter the activities of astrocytes and axonal sprouting, which may interfere 
with interpreting effects of treatment or a co-morbidity factor on recovery (Durukan & Tatlisumak, 
2007; Kumar et al., 2016). Hence, this model is not a good choice for my study.  
 
2.3.2 Photothrombotic Stroke Model 
The photothrombotic stroke model chosen for my study has several advantages for 
addressing my research questions. This model has proved useful in studying motor function (Moon 
et al., 2009; Becker et al., 2016) and mechanisms of neuronal repair and restoration (Carmichael 
et al., 2005; Clarkson et al., 2013). It was initially developed by Watson and his colleagues in 1985 
(Watson et al., 1985). In this model, an infarct is induced through the transcranial activation of a 
photosensitive dye, Rose Bengal, with a laser beam that has a wavelength of 532nm. The 
activation, in turn, generates reactive oxygen species, triggers the coagulation cascade, and forms 
a permanent thrombosis (Watson et al., 1985; McCabe et al., 2017). Our laboratory has recently 
published a refined method where the laser intensity can be tightly controlled and carefully 
monitored to increase the consistency of infarct size (Alaverdashvili et al., 2018).  
This technique has many advantages, such as high reproducibility, less invasive surgery 
(e.g., no craniotomy), and a relatively simple technique (Corbett et al., 2017). Being less surgically 
invasive is the primary consideration for my thesis project as invasive surgical procedures can 
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induce a hypermetabolic response that causes marked nutritional depletion, tissue wasting, and 
elevated energy and protein requirements (Twyman, 1997; Chapple et al., 2016); this is not a 
feature of stroke patients (Finestone et al., 2003). Therefore, the photothrombotic model was 
chosen for my thesis project to best mimic the nutritional and metabolic status of the clinical stroke 
population.  
In addition, the infarct can be induced in any specific location in the cortex, and the size can 
be accurately defined with stereotaxis. The photothrombotic model also has limitations. Firstly, 
the peri-infarct region, where the majority neuronal repair activities occur, is limited in size. In 
addition, it produces an immediate and vast vasogenic edema that is not seen in human stroke 
(Corbett et al., 2017). Furthermore, the rapidly developed photothrombosis is unusual in human 
stroke (Durukan & Tatlisumak, 2007; Bacigaluppi et al., 2010; McCabe et al., 2017). Although 
this makes it unsuitable for studying neuroprotective treatments, this is not a goal of my study.  It 
is an excellent choice to explore stroke-induced motor deficits and neuroplasticity (Carmichael et 
al., 2005; Moon et al., 2009; Clarkson et al., 2013) as such cellular changes in its peri-infarct 
region are comparable to those in the penumbra of MCAO models (Lee et al., 1996; Corbett et al., 
2017).  
 
2.4 Functional Assessment in Focal Ischemia Stroke Models in Rats 
2.4.1 Overview 
The Stroke Therapy Academic Industry Roundtable reports, initially developed in 1999 
(Stroke Therapy Academic Industry, 1999) and later updated in 2009 (Fisher et al., 2009) have 
emphasized the importance of measuring not only the infarct size (volume) but also functional 
outcomes in animal models of stroke; functional recovery is the primary endpoint in clinical trials, 
and histological findings do not always correlate well with the functional response in humans 
(Stroke Therapy Academic Industry, 1999). Both reports also point out that outcomes should be 
assessed during both the acute phase and the long term, which allows a dynamic picture of the 
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functional response and to establish whether any findings are sustained (Stroke Therapy Academic 
Industry, 1999; Fisher et al., 2009). Many behavior tests have been developed to evaluate post-
stroke motor function in rats. These include cylinder test (Schallert et al., 1997), Montoya staircase 
(Montoya et al., 1991), single pellet reaching (Whishaw et al., 1991), beam walking task 
(Goldstein & Davis, 1990), and horizontal ladder walking task (Metz & Whishaw, 2002). In my 
study, horizontal ladder walking task was selected to assess the walking ability in rats. 
 
2.4.2 Horizontal Ladder Walking Task 
The horizontal ladder walking task is a sensitive test that can quantitatively and qualitatively 
measure the skilled locomotion of each limb as well as the coordination between limbs (Metz & 
Whishaw, 2002; 2009). Side walls of the ladder are made of transparent Plexiglass, which are 19 
cm high and 1m long (Metz & Whishaw, 2002). Metal rungs (3mm diameter) are inserted into 
holes spaced evenly at 1mm on the bottom of the walls to create a walking platform. A basic, 
regular rung pattern is formed when rungs are placed into every other hole; this pattern is used in 
both training and functional assessment. Moreover, rungs can be spaced unevenly to create more 
challenging patterns that prevent rats from learning both relative and absolute locations of the 
rungs and thus increase the sensitivity of the test (Metz & Whishaw, 2002; 2009). A recent study 
demonstrated that the sensitivity could be further increased by changing the inclination of the 
ladder (upward or downward) (Antonow-Schlorke et al., 2013).  
After training, rats traverse the ladder back and forth without any reinforcement. The 
walking process of each rat on the ladder is videotaped and the foot placement of a limb in every 
step is scored frame-by-frame using a 7-category scale (Metz & Whishaw, 2002; 2009). Different 
scores are assigned to 7 type of limb placements, which include: correct placement when the mid-
portion of a paw is placed on the rung (score of “6”), partial placement when a limb is placed 
using either wrist/heel or digits/toes (score of “5”), correction when a limb is aimed for one rung 
but is placed on another or when a limb is quickly repositioned on one rung (score of “4”), 
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replacement when a limb is quickly shifted to another rung after being placed on the first rung 
(score of “3”), slight slip when a limb slips off a rung but does not cause a fall (score of “2”), deep 
slip when a limb slips off a rung and causes a fall (score of “1”), and total miss when a limb 
completely misses a rung and cause a fall (score of “0”) . An error refers to either a total miss, a 
deep slip, or a slight slip (Metz & Whishaw, 2002; 2009). The number of each type of foot 
placement and errors are counted and frequencies of each type of foot placement and errors relative 
to total steps are used as behaviour endpoints.  
The horizontal ladder walking task has been validated as a valuable behavioral test to assess 
skilled locomotion deficits in the motor system induced by stroke (Metz & Whishaw, 2009; 
Schonfeld et al., 2017). Moreover, it has been widely used in a body of pre-clinical stroke studies 
to evaluate the efficacy of drug therapies and rehabilitation regimen (Emerick & Kartje, 2004; 
Ploughman et al., 2007; Garcia-Alias et al., 2009; Paquette et al., 2009; Beltran et al., 2010; Sun 
et al., 2013; Jiang et al., 2016). For instance, using the ladder rung walking task one study 
demonstrated that rehabilitation initiated early after stroke significantly improved functional 
outcome but rehabilitation started 30 days after stroke had no such effect (Biernaskie et al., 2004). 
In another study, early anti-inflammatory intervention combined with rehabilitation improved 
functional recovery, as detected by a dramatically decreased error rate and an increased correct 
placement frequency of the stroke-affected forelimb in the ladder rung walking task (Liebigt et al., 
2012).  
Many advantages are associated with the use of the horizontal ladder walking task. The 
training process and each training session is relatively quick compared to other complex tests such 
as Montoya staircase and single pellet reaching (Schonfeld et al., 2017). The task allows a 
comprehensive examination of spontaneous walking ability in trained animals (Metz & Whishaw, 
2009). The ability to vary rung spacing provides the opportunity to further increase the sensitivity 
by challenging animals to walk on an unfamiliar surface (Schonfeld et al., 2017). More importantly 
for nutrition studies, food restriction is not required during testing (Metz & Whishaw, 2009), which 
is crucial in nutritional studies to avoid confounding the closely controlled nutritional intake. A 
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disadvantage, as with other behaviour tests that use ordinal rating scales, the interval between two 
scores from the 7-category scale in ladder rung walking does not reflect the numerical difference 
between two types of placements (Muir & Webb, 2000). Another limitation of this test is that 

















Chapter 3 METHODS AND MATERIALS 
 All experiments were approved by the University of Saskatchewan Animal Research Ethics 
Board and adhere to the Canadian Council on Animal Care guidelines for humane animal use. 
 
3.1 Experimental Design 
 Male, adult (12 weeks old) Sprague-Dawley (SD) rats (n = 87) were obtained from Charles 
River (QC, Canada). Rats were housed in pairs in a temperature (22oC) and humidity-controlled 
suite with a 12-hour light/dark cycle (7AM to 7PM). Food and water were provided ad libitum 
throughout the study, except for a short period of 5 days of food restriction (80% of ad libitum 
daily food intake) introduced at the beginning of the horizontal ladder task training. 
 The experimental design is shown in Figure 3.1. After acclimatizing for 1 week, rats were 
handled (5 min/rat) for 3 days and were then trained for 11 days on the horizontal ladder walking 
task. All rat started to receive the purified control diet (12.5% protein) 1 week before surgeries. 
Each rat was tested on the horizontal ladder on the 4th day prior to surgery to obtain pre-stroke 
baseline data. On day 0, each animal was assigned to either a photothrombotic stroke or a sham 
surgery. To assess functional deficits during the acute phase after stroke, each rat was tested in the 
horizontal ladder on day 2, after which rats were assigned to receive either the control diet or a 
low protein diet (0.5% protein).  
 Hence, two independent variables, nutritional intervention (CON or PEM) and surgical 
treatment (SHAM or ISCH), yielded four subgroups: i) the group of rats that received control diet 
and underwent sham surgery (CON-SHAM, n=22); ii) the group of rats that received control diet 
and underwent stroke surgery (CON-ISCH, n=20); iii) the group of rats that received the low 
protein diet and underwent sham surgery (PEM-SHAM, n=25); iv) the group of rats that received 
the low protein diet and underwent stroke surgery (PEM-ISCH, n=20). Animals from these 4 
subgroups were then assigned to either the subacute study (euthanized at post-stroke day 12, CON-
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SHAM n=8, CON-ISCH n=10, PEM-SHAM n=9, PEM-ISCH n=10) or the chronic study 
(euthanized at post-stroke day 28, CON-SHAM n=14, CON-ISCH n=10, PEM-SHAM n=16, 
PEM-ISCH n=10). In the subacute study, each rat was tested again in the horizontal ladder on post-
stroke day 11. In the chronic study, additional testing on the ladder was done on post-stroke days 
11 and 27. At the time of euthanasia and after perfusion, serum, liver, and brain samples were 
collected and stored at -80oC for further analysis. 
 
Figure 3.1 Experimental design. PT = photothrombotic. 
 
3.2 Horizontal Ladder Walking Training and Functional Assessment 
 Skilled walking was assessed through the horizontal ladder walking task. The method was 
adapted from the original version (Metz & Whishaw, 2002).  
 The horizontal ladder apparatus is composed of a transparent box [121cm x 15cm x 41cm 
(W x D x H)] with 4 clear Plexiglass side walls and an open bottom and top (Figure 3.2). To form 
a walking platform, metal rungs (3mm diameter) are inserted into holes (1cm apart) at the bottom 
of two side walls. A mirror is placed underneath the platform to facilitate visualizing the 
movements of the rats. The difficulty of the test can be altered by changing distances between 
rungs. In addition, employing different rung patterns prevents rats from memorizing absolute and 
29 
 
relative locations of rungs and hence increases the sensitivity of this test (Metz & Whishaw, 2002). 
At the training stage and pre-stroke baseline and acute phase testing, only the regular pattern 
(Figure 3.3A) was used, in which all rungs are 2cm apart. On days 11 and 27, animals were tested 
on both the regular pattern as well as an irregular pattern, in which distances between rungs 
alternate between 2cm and 3cm (Figure 3.3B).  
 
Figure 3.2 Horizontal ladder apparatus shown with the regular rung pattern.  
 
Figure 3.3 Illustrative images of the regular rung pattern (A) and the irregular rung pattern (B). 
 
3.2.1 Training 
 Each animal received one training session per day, and each session typically lasted 20-40 
minutes depending on the activity level of the animal. On day 1, rats were handled in the colony 
room (5min/rat). On day 2, banana-flavored sugar pellets (Bio-Serv #F05986, 10 pellets/rat) were 
given into cages after handling in the colony room. By doing so, rats became familiar with the 
food reward that would be used to encourage ladder walking during the training. On day 3, rats 
were handled and given sugar pellets in the behaviour suite. During the next 5 days (days 4-8), the 
rats were food restricted to 80% of their daily ad libitum food intake recorded from days 1 to 3; 
this was to motivate animals to walk across the ladder to obtain sugar pellets placed on the opposite 
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end. Once eaten, pellets were replaced immediately to maintain the motivation. During days 4 to 
6, two cage-mates were placed on the same ladder and could cross the ladder back and forth. 
Individual rat walking was initiated on day 7 and was continued until the end of the training. On 
day 9, free access to ad libitum food in their home cages was resumed and continued until the end 
of the experiment. On days 12 and 13, video recording equipment (a Sony 3CCD camcorder under 
a cold light source (Lowel Satellite 4)) was set up during the training to acclimatize rats to avoid 
the possibility of neophobia on testing days. By day 14, each individual rat was able to walk across 
the ladder without long pauses or hesitations, which indicated successful training (Metz & 
Whishaw, 2002). 
 
3.2.2 Pre-Stroke Baseline Testing 
 To measure the pre-stroke baseline performance, animals were tested on the regular rung 
pattern on the 4th day prior to surgeries. For each rat, 5 ladder crossings were recorded by the 
camcorder with a shutter speed of 1/1000s-1. One crossing was considered as a rat walking from 
one end of the ladder to the other.  
 
3.3 Photothrombotic Stroke and Sham Surgery 
 The procedure was modified from the original model (Watson et al., 1985) as described in 
a recent publication from our laboratory (Alaverdashvili et al., 2015b). The infarct was placed in 
the forelimb region of the motor cortex of the left hemisphere to induce a functional deficit in the 
contralateral (right) forelimb of the rat.  
 The rats were now approximately 16 weeks old (112-116 days). Anaesthesia induction was 
with 5% isoflurane and 100% O2. The scalp between the eyes and ears was shaved, and the tail 
was cleaned using warm water and chlorhexidine soap. The animal was then mounted facing down 
on a stereotaxic frame and was kept anaesthetized under a mixture of 2-4% isoflurane in 
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60%N2O/40%O2. Throughout the surgery, physiological parameters including pulse, oxygen 
saturation and respiration rate, were continuously monitored using a MouseOx Plus, a 
multiparameter monitor (Starr Life Science). To maintain the body temperature at approximately 
37oC, a feedback-regulated homoeothermic blanket was placed underneath the rat throughout the 
surgery; the temperature probe of the blanket was lubricated with Vaseline and inserted into the 
anus of the animal. A syringe containing rose Bengal (10mg/kg, prepared on the same day of the 
surgery and covered with aluminium foil to avoid photodegradation) was placed between the 
blanket and the animal to maintain a physiological temperature.  
 The shaved area on the head was cleaned 3 times with chlorhexidine soap followed by 3 
times with 70% ethanol. The remaining procedures followed aseptic techniques. A 2-3cm incision 
was made from the eyes to the ears along the midline. Coordinates of a 4x4 mm2 square on the 
skull (+3mm to -1mm anterior-posterior from Bregma and +1mm to +5mm lateral of midline) 
were defined by the stereotaxic system using a surgical bone drill. The skull was thinned with the 
drill directly over this area until underlying blood vessels were visualized. During the thinning 
process, drops of sterile saline and sterile cotton tips were used to clean the debris. A light-proof 
metal mask with a 4x4 mm2 window cut-out was centered on the thinned region of the skull to 
ensure a precise illumination to the region of interest to increase the reproducibility of the infarct. 
To aid visualizing tail veins, the tail was warmed up in warm water (~40oC) before a catheter (BD 
Insyte, 24GA 0.75IN) was inserted into a lateral tail vein. In some cases, a tourniquet was applied 
to the proximal end of the tail to help visualize tail veins. Once the catheter was inserted 
successfully and was filled with blood, the pre-warmed 1mL syringe (Luer Lock) filled with rose 
Bengal was attached to the catheter. The solution was slowly injected over 30 seconds following 
by flushing with ~0.5mL sterile saline. Upon finishing the injection, the pre-warmed laser beam 
(532nm, Beta Electronic, 4mm diameter) with a power density of approximately 290mW/cm2, 
which was controlled by a variable neutral density (ND) filter (Alaverdashvili et al., 2015b), was 
immediately placed over the thinned area for 10 minutes to induce ischemia. For sham surgeries, 
the rose Bengal was injected but no laser irradiation was applied. Following the laser illumination, 
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the incision was cleaned with sterile saline and sutured up (Look Nylon Suture, 4-0 USP). A dose 
of bupivacaine (2mg/kg, Marcaine) was injected subcutaneously at the base of the incision site, 
and sterile saline (10mg/kg/hr) was administered subcutaneously in the nape of the neck to replace 
fluid losses.  
 The rat was then placed on a clean paper towel in a clean cage. The cage was positioned 
such that only half the cage was on a warm heating blanket; thus, the animal, once mobile, had the 
option to choose the cool or warm side during recovery. Water was provided immediately after the 
procedure, and food was returned into the cage after one hour. Rats were closely monitored for the 
next 4 days, and after that, they were checked a minimum of once per day until the end of the 
study. Any signs of discomfort or tail inflammation were reported to the supervisor, and counsel 
was sought with the veterinarian. The need for euthanasia prior to the end of the study was rare 
but was performed according to our laboratory human intervention point checklist.  
 
3.4 Post-Stroke Diet Assignment 
 The composition of the control diet and the low protein diet purchased from Dyets, Inc. 
(PA, USA) was modified from the American Institute of Nutrition (AIN)-93M diet (Reeves et al., 
1993), as shown in Table 3.1. The antioxidant, tertiary-butylhydroquinone, included in the AIN-
93M diet was excluded from the purified diets. The control diet (12.5% protein) and the low protein 
diet (0.5% protein) are calorically equivalent. Our laboratory has previously shown that 16 week 
old male SD rats fed with the low-protein diet (0.5% protein) voluntarily decreased their food 
intake and thus reduced their caloric intake, which consequently produced a mixed state of protein 
and energy malnutrition (Andrade Ramos, 2013). Food intake per cage was recorded daily, and 
the body weight of each rat was recorded twice a week, except during the initial 4 days after surgery 




Table 3.1 Composition of experimental dietsa 
Components Control Diet (g/kg) 
(12.5% Protein) 
Low Protein Diet (g/kg) 
(0.5% Protein) 
Vitamin Free Casein 140.0 5.7 
L-Cystineb 1.8 0.1 
Sucrose 100.0 100.0 
Cornstarch 465.7 556.8 
Dextrinized Cornstarch 155.0 184.0 
Soybean Oil (without tBHQ) 40.0 40.0 
Cellulose 50.0 50.0 
Mineral Mixc 35.0 0 
Mineral Mixd 0 35.0 
Calcium Phosphate, dibasic 0  13.0 
Calcium Carbonate 0 2.9 
Vitamin Mixe 10.0 10.0 
Choline Bitartrate 2.5 2.5 
aPurified diets were purchased from Dyets Inc. (Bethlehem, PA, USA).  
bThe amount of L-cystine was proportional to the quantity of casein.  
cAIN-93M mineral mix (Reeves et al., 1993).  
dModified AIN-93M mineral mix with the deletion of calcium and phosphorus, an increase of potassium 
citrate·H2O from 28.0 to 226.6g/kg, and an increase of sucrose from 209.8 to 618.3g/kg.  
eAIN-93M vitamin mix (Reeves et al., 1993). 
 
3.5 Post-Stroke Functional Testing 
 There were three post-surgical testing times on the horizontal ladder: i) post-surgical day 
2 on the regular rung pattern, ii) post-surgical day 11 on both the regular and the irregular rung 
patterns; iii) post-surgical day 27 on both the regular and the same irregular patterns (only for the 
chronic study). For each rung pattern on each testing day, 5 ladder crossings were recorded for 
each individual rat. Walking performance on the regular pattern was tested prior to that on the 
irregular pattern. Between the two testing sessions on the same day, animals were returned to their 
colony room to rest for at least 1 hour to avoid low activity in the ladder on the second test.  
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3.5.1 Analysis of Skilled Walking 
 Recorded videos were analyzed frame-by-frame (Quick Time Software) by our laboratory 
technician, Megan Morgan, who was blinded to experimental groups. Based on the original 
method (Metz & Whishaw, 2002), the frequency of the rat making an error with its stroke-targeted 
forelimb was tabulated. An error refers to a slight slip, a deep slip or a total miss (Metz & Whishaw, 
2002). A ‘slight slip’ is when the targeted forelimb slips off a rung but does not cause a fall, 
whereas a ‘deep slip’ refers to when the targeted forelimb slips off a rung and causes a fall. A ‘total 
miss’ is when the targeted forelimb falls between the rungs without contacting any rungs and 
causes a fall. The total number of errors relative to the total number of steps walked yields the 
frequency of foot fault errors.  
 
3.6 Tissue Collection   
 On post-surgical day 12 (subacute study) or 28 (chronic study), animals were deeply 
anesthetized under a mixture of 5% isoflurane and 100% O2. Before perfusion, approximately 3mL 
blood was taken directly from the left ventricle of the heart and was collected into a glass tube to 
obtain the serum (see below). The animal was then transcardially perfused with saline for 5 minutes 
(~20mL/min). After saline perfusion, one lobe of the liver was removed and was immediately 
flash-frozen in liquid nitrogen. The perfusion was continued using 4% paraformaldehyde (PFA) 
solution for another 5 minutes (~20mL/min). The animal was then decapitated, and the brain was 
carefully extracted from the skull and preserved in ~200mL 4% PFA solution at first 24 hours. 
Upon PFA preservation, the brain was sequentially immersed into a series of sucrose solutions 
with increasing concentrations (10% to 20% to 30% sucrose in 0.1M phosphate buffer) to achieve 
cryoprotection and to avoid freezing artifacts. Once the brain sample sank to the bottom of the 
container in the final 30% sucrose solution, the cerebellum was removed. The rest of the brain 
sample was embedded in the optimal cutting temperature (OCT) compound (Tissue-Tek) and was 
frozen in liquid isopentane bathed in a mixture of dry-ice/acetone (-78oC) for 5 minutes or until no 
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bubbles were formed. All samples (blood serum, the liver, and the brain) were then stored at -80oC 
until further analysis.  
 
3.7 Serum Albumin Concentration 
 After being collected into a glass tube, the blood was left to clot at room temperature for 
45 to 90 minutes before being centrifuged at 1,500 x g (Allegra 25R Centrifuge, Beckman Coulter) 
for 10 minutes at 4oC. The serum was then aliquoted into several 0.6mL Eppendorf tubes chilled 
on ice before being stored at -80oC.  
The serum albumin concentration was determined by the bromocresol green method 
(Dumas et al. 1997). A series of standard solutions (2, 3, 4, 5, 6, and 7g/dL), made up from a stock 
bovine serum albumin solution (10g/dL), were used to plot the standard curve. A volume of 25µL 
of a standard, blank, or a serum sample was added to 5.0mL working bromocresol green solution 
(3 parts 0.1M succinate buffer, 1 part 0.6mM bromocresol green solution, and 4 g/L of 30% Brij-
35 [pH 4.2]). The blank contained only 5.025mL working bromocresol green solution. Each 
mixture was mixed 5 times using a micropipette to ensure homogeneity. After sitting for 30 
minutes at room temperature, 1mL of each mixture was pipetted into a 1.5mL disposable cuvette. 
The absorbance of each cuvette was read at 628 nm (SpectraMax M5, Molecular Devices). Blanks, 
standard solutions and serum samples were run in triplicate. A linear regression curve of 
absorbance was plotted relative to concentrations of standard solutions after subtracting the 
absorbance of blank samples. The concentration of each sample (in triplicate) was obtained from 
the linear regression analysis. The mean of the three concentrations was recorded as the 




3.8 Total Liver Lipid Content   
Liver lipid content was also analyzed as an indicator of protein-energy status, since it is 
increased in clinical PEM (Badaloo et al., 2005). Frozen liver samples were moved from -80oC to 
-20oC storage one day prior to the analysis. On the next day, the samples were thawed at room 
temperature for 1 hour. Approximately 0.5g of each liver sample was cut, weighed and placed into 
a pre-labelled glass vacutainer tubes. Next, 1 mL of 0.15M sodium chloride solution was added to 
each tube. The mixture in the tube was then homogenized (Polytron) at the speed of setting 7 for 
approximately 30 seconds. Another 1mL of 0.15M sodium chloride solution was used to rinse the 
homogenizer blade and was collected into the tube. After adding 5mL of a 2:1 mixture of 
chloroform and methanol, the tube was capped with a rubber stopper before being centrifuged at 
2,175 x g (Beckman Centrifuge Allegra 25 with TS-5.1 rotor) for 10 minutes at room temperature. 
Next, the upper aqueous layer was discarded, and approximately 1 gram of anhydrous sodium 
sulfate was added to the remaining mixture. After vigorously shaking the mixture, the solid was 
filtered out (#1 Whatman filter paper) and the filtrate was collected into another pre-weighed glass 
tube. The chloroform was evaporated using a vacuum centrifuge (30oC, 100millibars) for 2 hours. 
Tubes were cooled down to the room temperature before being re-weighed. The weight of dry liver 
lipid was obtained by subtracting the weight of the test tube from the weight after evaporation (a 
combined weight of test tube and final sample). Percent liver lipid content was determined as 
follows: the weight of the dry lipid/the wet weight of the liver sample × 100%. The analysis was 
run in duplicate (two specimens from the same liver), and the mean was recorded as the total liver 
lipid content.  
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3.9 Assessment of Infarct Volume  
 To assess the infarct volume in the brains collected from ischemic groups, frozen brains 
were sectioned into 28μm thick coronal slices that extended throughout the region of the infarct. 
Sham brains were also sectioned at the same brain coordinates to determine whether there was any 
unexpected cortical damage. Serial sections at 420μm intervals were stained with cresyl violet and 
then scanned into JPEG images (20x magnification, ScanScope CS scanner by Aperio).  
Due to some staining and processing artifacts, the infarct volume was estimated using two 
different methods. In the first method, the infarct area in the cortex of each section was directly 
outlined and the size was measured using the software, ImageJ (the National Institutes of Health, 
https://imagej.nih.gov/ij/). The infarct volume was calculated using the following formula: 
Infarct volume in the cortex of the injured hemisphere = average area of the infarct in the 
cortex of the injured hemisphere x interval between sections x number of sections. 
Although the intent was to place the infarct in the motor cortex, there was damage in the 
underlying corpus callosum in some brains. Ischemia in the white matter triggers different cell 
death pathways and neuronal repair mechanisms from those in the grey matter (Sozmen et al., 
2009). Therefore, it is important to distinguish the damage in the cortex from that in the corpus 
callosum (See Appendix A). The damaged area in the corpus callosum was traced in each section 
and was measured using ImageJ. The volume of brain damage in the corpus callosum and the total 
infarct volume were calculated using following formulas: 
 Infarct volume in the corpus callosum = average area of the infarct in the corpus callosum 
in the injured hemisphere x interval between sections x number of sections. 
Total infarct volume in the injured hemisphere = infarct volume in the cortex + infarct 
volume in the corpus callosum 
In the second method, areas of healthy uninjured cortex in each hemisphere were outlined and 
measured through ImageJ software. The region defined as cortical tissue was determined by using 
anatomical hallmarks (Paxinos & Watson, 2007). Although it is ideal to include the entire 
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hemisphere in such assessments (Clark et al., 2008), only the cortex in each hemisphere was 
measured due to staining and sectioning artifacts that damaged subcortical structures and 
precluded the possibility of outlining the entire hemisphere. The tissue loss in the injured 
hemisphere was calculated using following formulas modified from (Clark et al., 2008):  
Volume of tissue loss = remaining volume of the healthy uninjured cortex in the normal 
hemisphere – remaining volume of the healthy uninjured cortex in the injured hemisphere. 
Remaining healthy uninjured cortex in a hemisphere = average area of the remaining cortex 
in a hemisphere x interval between sections x number of sections. 
When sections were missing, data were calculated by summing areas in each available section 
and multiplying by the distance from the first and the last section acquired. 
 To assess whether there was any unexpected cortical damage that occurred during sham 
surgeries, stained sections of sham brains were carefully examined under a microscope (Nikon, 
H550L). Damage to the cortex in a sham brain was visualized as a cluster of dark, brown stained 
nuclei that represented necrotic tissue, comparing to purple stained healthy cells.  
 
3.10 Statistical Analysis   
 Statistical analyses were performed using SPSS 24.0 for Windows. For all analyses, a 
significant difference was considered as p<0.05. Data are described as mean ± SEM. 
 To determine whether there was any inherent physiological bias prior to the diet assignment 
on post-stroke day 2, physiological parameters (oxygen saturation, pulse rate, and the body 
temperature) acquired during surgeries for both subacute and chronic studies were analyzed using 
2-factorial Analysis of Variance (ANOVA). 
 Body weight and food intake data collected prior to the diet assignment on post-surgical 
day 2 were evaluated through independent t-test, with surgery as the independent variable. Body 
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weight data collected after the diet assignment were analyzed through 3-factorial repeated 
ANOVA, with surgery and diet as between-subject variables and time as the within-subject 
variable. An independent t-test was used to determine when changes in body weight first became 
significant between the pooled diet groups. Sample size was insufficient to conduct repeated 
measures ANOVA on the food intake data, since this was collected on a cage basis (with 1-2 rats 
per cage).  Thus, daily food intake after diet assignment was analyzed by 2-factorial ANOVA until 
a significant diet effect emerged. The serum albumin concentration and liver lipid content were 
analyzed by 2-factorial ANOVA. 
 The error rate on the regular rung pattern of the horizontal ladder walking task was 
analyzed by 3-factorial repeated ANOVA, with time as the within-subject variable and diet and 
surgery as between-subject variables. The focus was to analyze data collected from the chronic 
study (pre-stroke baseline and post-stroke days 2, 11, and 27). However, the data from the subacute 
study (pre-stroke baseline and post-stroke days 2 and 11) were also analyzed by the same approach 
to determine if results were consistent with those from the chronic study. As step 1, 3-factorial 
repeated ANOVA was performed on the error rate from pre-stroke baseline and post-stroke day 2 
to determine: a) whether there was any inherent bias in pre-stroke ladder training prior to 
assignment to diet and surgery groups (the independent variables), b) if stroke induced a functional 
deficit, and c) if there was any inherent bias in surgical groups prior to the dietary assignment on 
post-stroke day 2. When there was a significant time x surgery interaction, an independent t-test 
was performed on the pooled ISCH and SHAM groups at each time point to determine whether 
there was a significant stroke effect. As step 2, 3-factorial repeated ANOVA was performed on 
data from days 2, 11, and 27 to determine whether diet (PEM or CON) affected the error rate of 
the targeted forelimb. 
 For the analysis of data from the irregular rung pattern, a repeated ANOVA was not 
performed on the chronic study data (collected on days 11 and 27) since the irregular rung pattern 
was only novel on day 11 but not on day 27. Instead, the data were analyzed separately on each 
day by 2-factorial ANOVA, with diet and surgery as independent variables. Because the irregular 
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rung pattern was tested on day 11 in both subacute and chronic studies, the day 11 data from the 
two studies were combined and analyzed by 2-factorial ANOVA to examine how the results would 
be influenced by an increased sample size. When there was a diet x surgery interaction, a post-hoc 
Tukey’s HSD test was performed.  
 An independent t-test was used to compare infarct volume between CON-ISCH and PEM-
















Chapter 4 RESULTS 
4.1 Excluded Animals 
 Prior to the completion of the experiment, two animals were excluded. One CON-ISCH rat 
from the chronic study was excluded due to an inflamed tail from multiple failed attempts to inject 
the Rose Bengal dye in the tail vein during the surgical procedure. The other (CON-SHAM rat 
from the chronic study) was excluded due to an unexplained hyperplastic growth on the proximal 
region of the tail, which could induce systemic inflammation and potentially confound the 
experimental results. Upon a histological (cresyl violet staining) examination of the serial brain 
sections and the review of surgical records, one CON-ISCH rat from the subacute study was 
excluded since unsuccessful tail vein injections failed to induce brain ischemia. In addition, 22 rats 
from sham groups (8 - CON-SHAM - chronic study; 10 - PEM-SHAM - chronic study; 2 - CON-
SHAM – subacute; 2 - PEM-SHAM – subacute) were excluded due to unintended damage to 
cortical layers I and II in the surgically manipulated hemisphere. This was attributed to excessive 
force applied during drilling to thin the skull during surgeries. 
 
4.2 Physiological Parameters from Surgeries 
 Physiological parameters, including the level of oxygen saturation, pulse rate and the body 
temperature, measured during surgeries are shown in Table 4.1 A & B, respectively. The data 
were compared among the 4 assigned groups to assess whether there was any inherent 
physiological bias prior to the diet assignment on day 2. 
 In both studies, levels of oxygen saturation were well maintained across 4 groups. Two-
factorial ANOVA revealed that there was no surgical effect (psubacute=0.243, pchronic=0.121), diet 
effect (psubacute=0.066, pchronic=0.617), or surgery x diet interaction (psubacute=0.115, pchronic=0.345) 
on mean oxygen saturation. There was no surgery effect (psubacute=0.736, pchronic=0.496), diet effect 
(psubacute=0.806, pchronic=0.869), or surgery x diet interaction (psubacute=0.432, pchronic=0.567) on 
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mean pulse rate in either study. Ischemia significantly increased the body temperature in both the 
subacute (psubacute=0.007) and chronic (pchronic=0.001) studies. There was no diet effect 
(psubacute=0.056, pchronic=0.586) or surgery x diet interaction (psubacute=0.814, pchronic=0.892). The 
mean body temperature of combined ischemic groups (CON-ISCH and PEM-ISCH) was 
significantly higher than that of combined sham groups (CON-SHAM and PEM-SHAM). 
Table 4.1 Physiological parameters measured during surgeries 
A) Subacute study  







CON-SHAM 99 ± 0.1 321 ± 7.3 36.8 ± 0.2 
CON-ISCH 99 ± 0.1 325 ± 8.5 37.2 ± 0.2 * 
PEM-SHAM 98 ± 0.6 331 ± 13.2 36.4 ± 0.2 
PEM-ISCH 99 ± 0.1 320 ± 8.8 36.9 ± 0.1 * 
^ Physiological parameters are presented as mean ± SEM. ‡ CON-SHAM, n=6; CON-ISCH, n=9; PEM-
SHAM, n=7; PEM-ISCH, n=10. * Body temperature of ISCH groups was significantly higher than that of 
SHAM groups (2-factor ANOVA, p=0.007) 
 
B) Chronic study  







CON-SHAM 99 ± 0.1 330 ± 13.3 36.7 ± 0.1 
CON-ISCH 99 ± 0.2 328 ± 12.6 37.3 ± 0.1 * 
PEM-SHAM 99 ± 0.2 337 ± 7.2 36.7 ± 0.2 
PEM-ISCH 99 ± 0.2 324 ± 4.4 37.4 ± 0.2 * 
^ Physiological parameters are presented as mean ± SEM. ‡ CON-SHAM, n=6; CON-ISCH, n=10; 
PEM-SHAM, n=6; PEM-ISCH, n=10. * Body temperature of ISCH groups was significantly higher than 
that of SHAM groups (2-factor ANOVA, p=0.001)  
 
4.3 Body Weight   
 Post-surgical body weights over the 28-day period in the chronic study are shown in Figure 
4.1. Prior to the diet assignment on day 2, body weights between pooled SHAM and ISCH groups 
were not different from each other (independent t-test, p=0.074). Three-factorial repeated 
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ANOVA analysis of body weights after day 2 demonstrated a significant time x diet effect (within-
subject effect, p=0.001). Neither a significant time x surgery effect (p=0.999) nor a significant 
time x surgery x diet effect (p=0.996) was revealed.  An independent t-test demonstrated that the 
body weight of the pooled PEM groups first became significantly lower than that of pooled CON 
groups on day 15 (p=0.008) and there was a trend on day 11 (p=0.059). Over the 28 days, the two 
CON groups increased their body weight from the baseline (the day of surgery) by a mean of 
17.7% whereas the two PEM groups decreased theirs by 8.6%. This resulted in a difference of 
22.0% between control and malnourished animals in the final body weight on day 28.  
 
Figure 4.1 Mean (±SEM) body weight in the chronic study. Day 0 was the surgery day (the 
baseline). Dashed vertical line indicates the day on which rats were assigned to receive either 
control or low protein diet. * indicates the first day on which the body weight of the combined 




 Body weights from the subacute study are shown in Figure 4.2. Note the higher body 
weights at the baseline, even though they were received at an identical age to those rats in the 
chronic study. A bias was detected on day 0 in that the rats to be assigned to SHAM surgery 
weighed significantly more that those to be assigned to ISCH surgery (independent t-test; p=0.038). 
This bias of higher body weight in the pooled SHAM groups persisted to day 2 after surgery and 
prior to the diet assignment (independent t-test, p=0.028). Nonetheless, the body weight change in 
the subacute study (Figure 4.2) showed a similar pattern to that of the first 12 days in the chronic 
study (Figure 4.1). That is, the low protein diet fed groups (PEM) gradually lost weight whereas 
control diet fed rats continuously gained weight. Three-factorial repeated measures ANOVA 
applied to body weights from days 3 to 12 revealed a significant time x diet effect (within-subject 
effect, p<0.001). The lower body weight in the PEM groups first became significant on day 11 
(p=0.030). By day 12, CON animals had increased their body weight by 5.5%, compared to their 
baseline body weight. PEM rats decreased their body weight by 3.3 % over the 12 days. This 
resulted in a difference of 12.9% in the final body weight between control and malnourished 






Figure 4.2 Mean (±SEM) body weight in the subacute study. Day 0 was the surgery day (the 
baseline). The dashed vertical line indicates the day on which rats were assigned to receive either 
control or low protein diet. *Indicates an inherent bias at baseline in surgical group, with pooled 
SHAM groups weighing more than ISCH groups (independent t-test, p=0.038). #Indicates the first 
day on which the pooled PEM groups weighed significantly less than the pooled CON groups 
(independent t-test, p=0.030). 
 
4.4 Food Intake 
 The daily food intake per rat collected on a cage basis from the chronic study is shown in 
Figure 4.3. Prior to the diet assignment, the food intake of pooled SHAM and ISCH groups was 
not significantly different (independent t-test, p=0.453). Two-factorial ANOVA analysis applied 
to daily food intake after the diet assignment identified an independent diet effect beginning on 
post-surgical day 11, with the PEM groups eating significantly less (p=0.015). Neither an 
independent surgical effect nor a surgery x diet interaction was found at any time point (p>0.05). 
The difference in average food intake between control and PEM groups during the period between 




Figure 4.3 Mean (±SEM) daily food intake (g/rat) in the chronic study estimated based on cage 
data. Day 0 was the surgery day (the baseline). The dashed vertical line indicates the day on which 
rats were assigned to receive either control or low protein diet. # indicates the first day on which 
the food intake of pooled PEM groups first became significantly lower than that of CON groups 
(2-factor ANOVA; p=0.015). 
 
 The daily food intake per rat in the subacute study is shown in Figure 4.4. On day 1, the 
food intake of pooled ISCH groups was significantly lower than that of pooled SHAM groups 
(independent t-test, p=0.022). However, no difference was found between SHAM and ISCH 
groups on either day 0 or day 2 prior to diet assignment (independent t-test, pday0=0.123, 
pday2=0.156). After day 2 (diet assignment), the pooled PEM groups gradually reduced food intake, 
which became significantly lower than that of the CON groups on day 12 (2-factor ANOVA, 
p=0.025). Neither an independent surgical effect nor a surgery x diet interaction was found at any 




Figure 4.4 Mean (±SEM) daily food intake (g/rat) in the subacute study that estimated based on 
cage data. Day 0 was the surgery day (the baseline). The dashed vertical line indicates the day on 
which rats were assigned to receive either control or low protein diet. *indicates significantly lower 
food intake in pooled ischemic groups compared to combined sham groups (independent t-test, 
p=0.022). # depicts when the food intake of pooled PEM groups first became significantly lower 
than that of CON groups (2-factor ANOVA, p=0.025). 
 
4.5 Serum Albumin Concentration 
 The low protein diet, resulting in PEM, significantly reduced the concentration of serum 
albumin on both day 12 (2-factorial ANOVA, p=0.001) and day 28 (2-factorial ANOVA, p=0.001) 
(Figure 4.5). Neither a surgery x diet interaction (pday12=0.883, pday28=0.552) nor an independent 
surgical effect (pday12=0.087, pday28=0.420) was found on either day. On day 12, the serum albumin 
concentration in malnourished rats was 14.5% lower than that in control animals. With progression 
of malnutrition to day 28, the serum albumin level of PEM animals was further decreased, resulting 




Figure 4.5 Mean (±SEM) serum albumin concentration on days 12 and 28. Animals were assigned 
to receive either control or low protein diet on day 2 after surgery. # indicates a main effect of diet 
(2-factorial ANOVA, pday12<0.001, pday28<0.001). 
 
4.6 Total Liver Lipid Content 
 The impact of the low protein diet on the total liver lipid content is shown in Figure 4.6. 
On day 12, no significant effect of either diet (p=0.812; 2-factorial ANOVA) or surgery (p=0.624) 
or their interaction (p=0.586) was found. On day 28, there was a trend for an increase in the liver 
lipid content in the PEM groups (p=0.051), whereas there was neither a significant surgery effect 




Figure 4.6 Mean (±SEM) total liver lipid content on days 12 and 28. Animals were assigned to 
receive either control or low-protein diet at day 2 after surgery. There was a trend for the pooled 
PEM groups to have higher liver lipid content on day 28 (2-factorial ANOVA, p=0.051). 
 
4.7 Functional Assessment: Skilled Walking on the Horizontal Ladder  
4.7.1 The Error Rate of the Affected Forelimb on the Regular Rung Pattern 
 For the chronic study (Figure 4.7), 3-factorial repeated ANOVA applied to the error rate 
of the affected forelimb at baseline and day 2 revealed a significant time x surgery interaction 
(within-subject effect, p<0.001).  The error rate is the sum of rates of slight slip, deep slip and total 
miss (Metz & Whishaw, 2002). There was no time x diet bias (within-subject effect, p=0.573) or 
time x diet x surgery interactions (within-subject effect, p=0.692). No difference in performance 
between pooled ISCH and SHAM groups at pre-stroke baseline was found (independent t-test, 
p=0.733). The error rate of the affected forelimb of the pooled ISCH groups (32.4 ± 3.1%) was 
significantly higher than that of the SHAM groups (4.1 ± 1.6%) on day 2 after stroke (independent 




Figure 4.7 Error rate (mean ± SEM) of the affected forelimb on the ladder regular rung pattern in 
the chronic study. Animals were assigned to receive either control or low-protein diet at day 2 after 
surgery (before diet assignment). * indicates error rate was increased in ISCH groups on day 2 as 
determined by 3-factorial repeated ANOVA (within-subject effect, p<0.001) and independent t-
test (p=0.001).  
 
 For the chronic study, the analysis of the error rate of the affected forelimb from days 2, 
11, and 27 (post-stroke performance) by 3-factorial repeated ANOVA revealed a significant time 
x surgery interaction (within-subject effect, p=0.001) (Figure 4.7) that was due to the increased 
errors in the ISCH groups on day 2. There was no time x diet (within-subject effect, p=0.558) or 
time x diet x surgery interactions (within-subject effect, p=0.394). No differences in the error rate 
between SHAM and ISCH groups were found after day 2 (independent t-test, pday11=0.758, 
pday27=0.797). 
 The error rate on the regular rung pattern in the subacute study was also analyzed to 
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determine whether changes were consistent with those in the chronic study (Figure 4.8). Three-
factorial repeated ANOVA analysis of pre-stroke baseline and day 2 data revealed a significant 
time x surgery effect (within-subject effect, p<0.001). An independent t-test found that the error 
rate of ISCH groups was significantly increased on day 2 (p<0.001). In addition, there was a 
significant time x diet effect (bias) between pre-stroke baseline and day 2 (within-subject effect, 
p=0.030). At the baseline, animals that would be later assigned to CON groups, especially the 
CON-SHAM group, had a higher error rate than that of animals that would be assigned to the PEM 
groups (independent t-test, p=0.034). Analysis of the error rates on days 2 and 11 by 3-factorial 
repeated ANOVA showed a significant time x surgery effect (within-subject effect, p<0.001). The 
error rates in the ISCH groups were significantly higher than those of SHAM groups on days 2 
and 11 (independent t-test, p=0.028). There was no time x diet (within-subject effect, p=0.174) or 
time x diet x surgery interactions (within-subject effect, p=0.243). Overall, the trend of changes in 





Figure 4.8 Error rate (mean ± SEM) of the affected forelimb on the ladder regular rung pattern in 
the subacute study. Animals were assigned to receive either control or low-protein diet at day 2 
after surgery. *indicates a significantly higher error rate in the ISCH groups (independent t-test, 
pday2<0.001, pday11=0.028).  # significant time x diet effect (pre-diet assignment bias) with rats to 
be later assigned to CON groups having a higher error rate (3 factor ANOVA repeated measures 
within-subject effect, p=0.030 and independent t-test, p=0.034). 
 
4.7.2 The Error Rate of the Affected Forelimb on the Irregular Rung Pattern 
 In the chronic study, the error rate of the affected forelimb on the irregular rung pattern on 
days 11 and 27 analyzed by 2-factorial ANOVA demonstrated a significant main effect of ischemia 
on day 11, whereby the ISCH groups had a higher error rate than the SHAM groups on the novel 
rung pattern (2-factorial ANOVA, p=0.009) (Figure 4.9A). There was no independent diet effect 
(p=0.124), but the diet x surgery interaction showed a trend on day 11 (p=0.075). The higher error 
rate in the ISCH groups was sustained until day 27, even though the rung pattern was no longer 
novel (p<0.001) (Figure 4.9B). Neither an independent diet effect (p=0.549) nor a diet x surgery 
interaction (p=0.155) was found on day 27. 
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 In the subacute study, a diet x surgery interaction was found in the error rate of the affected 
forelimb on the irregular pattern on day 11 (2-factorial ANOVA, p=0.002) (Figure 4.10). The 
error rate of the PEM-ISCH group were significant higher than that of CON-ISCH (p=0.023; 
Tukey’s HSD test) and PEM-SHAM (p=0.006) groups, but not different from that of the CON-
SHAM group (p=0.429). There was no difference in the error rate among CON-SHAM, CON-
ISCH and PEM-SHAM groups (Tukey’s HSD, p>0.05). 
Since the irregular rung pattern was tested on day 11 in both chronic and subacute studies 
with identical study design, the data from the two studies were also pooled to increase the statistical 
power (Figure 4.11). Two-factorial ANOVA analysis of the pooled data revealed a significant 
surgery x diet interaction (p=0.001), with a significantly higher error rate in the PEM-ISCH group 
than those of the other three groups (vs CON-SHAM p=0.007, vs PEM-SHAM p<0.001, vs CON-
ISCH p=0.001; Tukey’s HSD test,). Error rates of CON-SHAM, CON-ISCH, and PEM-SHAM 










Figure 4.9 Error rates (mean ± SEM) of the affected forelimb on the ladder irregular rung pattern 
of the chronic study at day 11 (A) and day 27 (B). * indicates a significantly higher error rate in 
the ISCH groups, as compared to SHAM groups (2-factorial ANOVA, pday11=0.009, 






Figure 4.10 Error rate (mean ± SEM) of the affected forelimb on the ladder irregular rung pattern 
from the subacute study at day 11. * indicates a significant higher error rate in the PEM-ISCH 
group than that of the CON-ISCH (Tukey’s HSD, p=0.023) and PEM-SHAM (Tukey’s HSD, 
p=0.006) groups. The CON-SHAM group was not different from any of the other three groups 
(p>0.05). CON-SHAM, n=6; CON-ISCH, n=9; PEM-SHAM, n=7; PEM-ISCH, n=10. 
 
Figure 4.11 Error rate (mean ± SEM) of the affected forelimb on the ladder novel and irregular 
rung pattern on day 11: analysis of pooled data from the chronic and subacute studies. * indicates 
a significantly higher error rate in the PEM-ISCH group as compared to all other groups (Tukey’s 
HSD test, to CON-SHAM p=0.007, to PEM-SHAM p<0.001, to CON-ISCH p=0.001). CON-




4.8 Infarct Volume Assessment 
Representative images of the infarct in CON-ISCH and PEM-ISCH brains observed on days 
12 and 28 are shown in Figure 4.12 A-D. On day 12, no significant difference between the two 
groups was revealed for infarct volumes in the cortex (p=0.600; independent t-test), damage in the 
corpus callosum (p=0.318), or total infarct volume (p=0.528) (Figure 4.13). Tissue loss in the 
injured hemisphere also did not differ between PEM-ISCH and CON-ISCH groups (p=0.890). 
Similarly, on day 28, there was no significant difference between experimental groups in cortical 
infarct volume (p=0.635), corpus callosum damage (p=0.740), total infarct volume (p=0.723), or 











    
         
Figure 4.12 Representative cresyl violet stained images of coronal brain sections (28µm thick). A, 
CON-ISCH brain at post-stroke day 12; B, PEM-ISCH brain at post-stroke day 12; C, CON-ISCH 
brain at post-stroke day 28; D, PEM-ISCH brain at post-stroke day 28. Varied colour intensity in 







Figure 4.13 Infarct volumes (mean  SEM) on post-stroke day 12. Animals were assigned to 
receive either control diet (CON-ISCH) or low protein diet (PEM-ISCH) on day 2 after surgery. 
There were no significant differences between CON-ISCH and PEM-ISCH groups for any 
endpoint (independent t-test, p>0.05). CON-ISCH, n=9; PEM-ISCH, n=10. 
 
 
Figure 4.14 Infarct volumes (mean  SEM) on post-stroke day 28. Animals were assigned to 
receive either control or low protein diet on day 2 after surgery. There were no significant 
differences between CON-ISCH and PEM-ISCH groups for any endpoint (independent t-test, 




Chapter 5 DISCUSSION  
Well-characterized rat models of PEM (Alaverdashvili et al., 2015a) and cortical stroke 
(Alaverdashvili et al., 2015b) were used to test the hypothesis that protein-energy malnutrition 
developing after stroke would impair functional recovery. The major finding is that post-stroke 
PEM induced by a low-protein diet worsened the recovery in walking ability without altering the 
infarct size. However, this effect of PEM was evident only under the most challenging condition. 
The finding partially supports the hypothesis and demonstrates that post-stroke PEM can be 
detrimental to stroke recovery. Therefore, clinical measures should be taken to prevent and treat 
this common co-morbidity.  
Post-stroke protein-energy malnutrition was successfully induced by feeding a low protein 
(0.5%) diet to adult male rats beginning on day 2 after stroke. Evidence for PEM was provided by 
the decrease in body weight, food intake, and serum albumin concentration, which is consistent 
with our previous results (Andrade Ramos, 2013; Alaverdashvili et al., 2015a; Matwee, 2016). 
There was also a strong trend for increased total liver lipid content in low dietary protein-fed 
groups, which was only evident by day 28. This provides further evidence of protein-energy 
malnutrition. Comparing with our previous studies where a significantly increased total liver lipid 
was typically found in malnourished rats (Andrade Ramos, 2013; Alaverdashvili et al., 2015a; 
Matwee, 2016), the large variability seen in my CON-SHAM group likely influenced the statistical 
result. Although there was an initial bias in body weight despite random group assignment, the 
pattern of changes in body weight and food intake induced by the low dietary protein in the 
subacute study resembled that of the first 12 days of data from the chronic study. The decline in 
serum albumin concentration was seen on day 12. In fact, this decrease occurs as early as 3 days 
after introducing a low protein diet (Alaverdashvili et al., 2015a). It is important to mention that 
serum albumin concentration is not a specific marker of PEM; being a negative acute phase protein, 
it can be affected by both dietary amino acid supply and an acute phase response (Qu et al., 1996). 
Thus, other nutritional indices, such as food intake, body weight, and liver lipid, were important 
to confirm the nutritional status.  
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The stroke model introduced some challenges in testing the hypothesis that post-stroke 
PEM would delay or reduce functional recovery. The increased error rate on the horizontal ladder 
at post-stroke day 2 in two ischemic groups demonstrated that a deficit in skilled walking was 
induced by stroke (Figure 4.7). However, when tested on the regular rung pattern again on post-
stroke days 11 and 27, malnourished and control rats subjected to stroke from both studies showed 
almost complete recovery, with their function resembling that observed in sham groups (Figure 
4.7). This demonstrated that the permanent functional deficit aimed for was not achieved. An ideal 
recovery profile after stroke in a preclinical animal model should be incomplete, mirroring that of 
many stroke patients (Krueger et al., 2015; Corbett et al., 2017). Besides not providing a good 
mimic of a stroke patient, this limitation reduced the sensitivity to detect any potential effects of 
PEM, since recovery occurred before PEM could fully develop. The small but statistically 
significant differences among groups observed in skilled walking data between subacute and 
chronic studies also demonstrate the high variability that is common to behavioral studies and 
emphasize the need to use large sample sizes for behavioral endpoints. In these two studies, a total 
of 22 sham rats had to be excluded due to the unintentional cortical damage caused by excessive 
force applied during skull drilling during surgeries; this resulted in the small sample size of the 
sham groups.  
Increasing the walking challenge in the ladder did reveal a more persistent walking deficit 
after stroke. When challenged with a novel irregular ladder rung pattern on day 11 after stroke, 
and the same irregular pattern on day 27, a higher error rate was found in well-nourished (control) 
rats exposed to stroke, compared to sham groups. Thus, CON-ISCH animals had not completely 
recovered from their stroke deficit. The irregular rung pattern, which was more challenging and 
novel (but only on day 11), mimics the “real life” environment with its variety of walking 
challenges and unpredictable obstacles that require adaptations.  
The added sensitivity of the irregular rung pattern also discerned that PEM exerted some 
detrimental effects on post-stroke walking recovery that was dependent on the extent of the 
walking challenge presented. The error rate on the irregular pattern in the PEM-ISCH group was 
61 
 
significantly higher than that of each of the other three groups on day 11 when data of subacute 
and chronic studies were pooled together to increase the power (Figure 4.11). This indicates that 
protein-energy malnutrition decelerated the rate of walking recovery. Note, however, that this was 
not a consistent finding when the data from subacute and chronic studies were individually 
analyzed. On post-stroke day 27, when the irregular rung pattern was no longer novel, the PEM-
ISCH group performed similarly to the CON-ISCH group (Figure 4.9B). This might indicate that 
PEM impairs the ability to overcome novel walking obstacles efficiently. Testing of this 
hypothesis would require further studies with repeatedly novel rung patterns, versus familiar ones, 
presented at several different times after stroke. Nevertheless, my results suggest the importance 
of treating post-stroke protein-energy malnutrition to achieve optimal recovery after stroke. 
Detrimental effects of PEM on recovery of walking ability are not explained by an increase 
in infarct sizes. Using two methods to evaluate the volume of brain damage, there was no 
difference in infarct sizes between PEM-ISCH and CON-ISCH animals on either day 12 or day 28 
(Figures 4.13 and 4.14). Although it is ideal to include the entire hemisphere in such assessments 
(Clark et al., 2008), only the cortex in each hemisphere was examined due to staining and 
sectioning artifacts that damaged subcortical structures and precluded the possibility of outlining 
the entire hemisphere. Overall, this finding is in line with our previous observations with both 
PEM pre-existing at stroke onset (Alaverdashvili et al., 2018) and PEM developing after stroke 
(Matwee, 2016). Since the experimental diet was not started until post-stroke day 2, it was not 
expected that PEM would influence the infarct size as the infarct core should have been well 
developed by then (Lee et al., 1996). Thus, effects of PEM on post-stroke recovery of walking are 
exerted through other mechanisms. 
 There were no differences between the two ischemic surgical groups (later assigned to 
PEM or CON diet) in the physiological parameters measured during the surgery. Thus, there was 
no confounding influence of these variables on study results. Mean body temperatures of ischemic 
groups were higher than those of sham groups by 0.5 degree in both subacute and chronic studies. 
It has been previously reported that certain stroke models can induce changes in the body 
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temperature while others do not (Klahr et al., 2017). Although hyperthermia is known to increase 
infarct volume, such an effect typically requires a dramatic increase (2-3 degrees) (Reglodi et al., 
2000; Meng et al., 2012). 
There are several mechanisms by which post-stroke PEM could worsen recovery of walking 
ability. First, our previous results demonstrated that PEM alone (without stroke) can induce a gait 
abnormality in the horizontal ladder walking task in adult rats, which can be partially explained by 
selective skeletal muscle atrophy in hindlimbs (Alaverdashvili et al., 2015a). However, this did 
not cause an increase in the error rate on the horizontal ladder, such as was observed after stroke. 
Secondly, while PEM pre-existing at stroke onset can attenuate microglia and astrocyte activation 
in the peri-infarct area at 3 days after stroke (Alaverdashvili et al., 2018), it is possible that PEM 
developing after stroke could also influence the stroke-induced glial response. Thirdly, I examined 
expression in the peri-infarct region of two axon terminal proteins that serve as markers for 
synaptic remodeling, GAP-43 (Carmichael et al., 2005) and synaptophysin (Stroemer et al., 1995), 
in my related nonthesis research,. No significant differences were found between PEM-ISCH and 
CON-ISCH animals on either day 12 or day 28 (unpublished data), suggesting that PEM may not 
influence walking recovery through the modification of neuroplasticity in the peri-infarct region. 
However, the immunohistochemical approach used was limited in power, being semi-quantitative 
in nature, and we examined only two neuroplasticity-related proteins. A more comprehensive 
analysis would be required to exclude this mechanism.  
Canadian Stroke Best Practice Guidelines recommend that nutritional status in stroke 
patients should be screened within 48 hours of admission and those with suspected malnutrition 
should be referred to clinical dietitians for detailed assessments (Casaubon et al., 2016). 
Rescreening for changes in nutritional status is also recommended throughout the hospital stay and 
prior to discharge (Hebert et al., 2016). Periodically, rescreening should be carried out in 
rehabilitation and community settings to facilitate creating the optimal management plan for 
individual patients (Hebert et al., 2016). Findings from this thesis project support these national 




The study had several strengths and limitations. By using well established protein-energy 
malnutrition (Alaverdashvili et al., 2015a) and photothrombotic stroke (Alaverdashvili et al., 
2015b) models, it was possible to study the effect of post-stroke PEM on stroke recovery without 
confounding influences inherent in complex patients in clinical studies. This allows a cause and 
effect relationship to be studied. Another strength of the study was the inclusion of a functional 
outcome, the major end point in clinical studies (Stroke Therapy Academic Industry, 1999), at 
acute, subacute and chronic post-stroke stages, in order to study effects on the progress of stroke 
recovery. Including a familiar regular rung pattern and an irregular pattern (with and without 
novelty) provided different degrees of walking challenge and increased the sensitivity of the task 
for testing the effects of PEM. As noted above, the primary study limitation was that a more severe 
and lasting functional deficit was not achieved with the stroke model. This reduced the sensitivity 
to detect any potential effects of the PEM, since recovery on the easy walking paradigm occurred 
before PEM could completely develop. Another limitation discussed above was the unfortunate 
loss of a significant number of sham-operated rats, which resulted in unequal sample sizes across 
experimental groups. A more complete understanding of the effects of PEM on motor recovery 
after stroke would have been obtained by employing a battery of motor behavior tasks that are 
validated for cortical stroke models. Such tests include the Montoya staircase (Montoya et al., 
1991), cylinder task (Schallert, 2006), tapered beam walking task (Goldstein & Davis, 1990; 
Schallert et al., 2002; Zhao et al., 2005), and single pellet reaching (Whishaw et al., 1991). 
Unfortunately, our laboratory has shown that tests that require extensive food rewards for training, 
such as the Montoya staircase that assesses skilled reaching, are not valid for studies of PEM as it 
was found in our lab that the motivation for obtaining sugar pellets was significantly elevated in 
malnourished rats (unpublished data). Therefore, one might only be assessing motivation instead 
of assessing motor function. The cylinder task has been utilized in our previous studies, and it was 
shown that post-stroke PEM prevented recovery of use of the affected forelimb during spontaneous 
exploration (Matwee, 2016). In future, the tapered beam walking task would be a useful addition 
to the horizontal ladder to investigate the effect of PEM on post-stroke skilled walking. Rats make 
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fewer compensatory adjustments in this task, allowing one to measure a deficit unconfounded by 
compensation (Schallert et al., 2002).   
The study results leave many unanswered questions that deserve further investigation. 
Different infarct sizes could be used to study effects of untreated PEM on varying degrees of 
stroke-induced walking deficits. Using repeatedly novel irregular rung patterns on the ladder at 
several post-stroke times could be used to test the possibility that PEM impairs the ability to 
overcome novel walking obstacles after stroke. Underlying mechanisms through which PEM 
interferes with walking recovery after stroke also require further investigation. As elderly 
individuals are most vulnerable to stroke (Livingston-Thomas et al., 2016), an important future 
experiment would be to investigate the effects of post-stroke PEM in aged animals.  
In addition, a growing body of evidence has demonstrated secondary damage in brain regions 
distal to a primary cortical infarct (e.g. thalamus and hippocampus) in both human patients and 
animal models (Zhang et al., 2012; Carrera & Tononi, 2014). These secondary brain injuries have 
been associated with both motor and cognitive deficits (Tamura et al., 1991; Zhang et al., 2012; 
Buma et al., 2013; Carrera & Tononi, 2014). Such secondary injuries have not been studied in a 
photothrombotic stroke model, which would be interesting to investigate in the future. Since PEM 
(without stroke) can cause morphological (Andrade et al., 1996; Lukoyanov & Andrade, 2000) 
and functional abnormalities in the hippocampus (Nakagawasai et al., 2006; Wang & Xu, 2007; 
Soares et al., 2013; Belluscio et al., 2016; Perez-Garcia et al., 2016), it would be of interest to 
investigate whether PEM also influences post-stroke recovery by either aggravating secondary 
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This set of images of coronal sections stained with cresyl violet from a post-stroke D28 
CON-ISCH brain demonstrates a representative series of images used to evaluate infarct volume.  
Each section is 28 µm thick and the sections are 420 µm apart. The yellow tracing separates the 
outline of cortical damage from the damage to the corpus callosum (the first method in section 
3.9).  
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